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ABSTRACT
PSYCHONEUROIMMUNOLOGY AND HEALING TOUCH IN HIV DI SEASE
By Jo Lynne Wheeler Robins, Ph. D . , RN
The purpose of this study was to ascertain the effects of Healing Touch (HT) on
well-being and neuroendocrine function in individuals living with HIV disease. A total of
27 males completed the 4-week HT intervention. Each weekly HT session lasted 3 0
minutes and consisted o f only the chakra connection. Because o f the small sample size and
the impact of gender on neuroendocrine and immune function, women were not included
in this study. Dependent variables included well-being as measured by three well-being and
two psychological distress instruments, serum serotonin, salivary DHEA and cortisol, and
a variety of enumerative and functional measures of immune function A pretest-posttest
design experimental design including a wait-list control group was used. Multivariate
analysis of covariance was used to test the research hypotheses followed by univariate
analysis of variance to detect the contribution of individual variables to the overall
multivariate models. It was hypothesized that HT would increase participant well-being,
serum serotonin and salivary DHEA; decrease salivary cortisol; and improve immune
function in individuals living with HIV disease. All of the research hypotheses were
rejected. Discussion of the results as well as directions for future research are presented.

VI

Chapter 1
Introduction
Psychoneuroimmunology (PNI) is the study of the complex relationships among
behavior and the neuroendocrine and immune systems. Bi-directional communication
pathways exist between the neuroendocrine and immune systems. In humans, it is thought
that certain behaviors affect these interactions and ultimately health outcomes (Ader,
1 992; Ader, Cohen, & Felton, 1 995; Black, 1 995). PNI is an outgrowth of research done
over 40 years ago exploring the effects of stress on the immune system. In the late 1 970's
the discovery of endorphins and their role in endogenous pain control was pivotal in the
emergence of psychoneuroimmunology as a significant field of study (Poole, 1 993 ).
Evidence suggests that endorphins as well as other chemicals produced by the
neuroendocrine and immune systems are part of an intricate mind-body network operating
to preserve health and mediate disease processes (Black, 1 994; Dossey, Keegan, Guzzetta,
& Kolkmeier, 1 995)

Peptides in the form of neurotransmitters, for example, mediate intercellular
communication throughout the brain and body. These peptides and their receptors are the
"biochemical correlates of emotions" (Pert, 1 993, p. 1 78) According to Pert, the
discovery of mood-altering chemicals that interact with the immune system implies that it
should be possible for individuals to achieve a mental state that positively affects the
immune system.
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A variety of therapies, including energy therapies, such as healing touch, may have
the potential to induce a mental state conducive to enhanced immune function. For
thousands of years, in eastern as well as western thought, the human body has been
conceptualized as an energy field. It is conceived as a manifestation of universal energy,
the basic constituent and source of all life. The human energy field ( HEF) is a "luminous
body that surrounds and interpenetrates the physical body, emits its own characteristic
radiation and is usually called the aura" (Brennan, 1 987, pA l ). The HEF or aura is
comprised of seven layers, with each layer having its own particular appearance and
function. Each layer contains chakras, which are essentially energy vortexes that connect
the HEF to the environmental and universal energy fields. Each chakra is thought to
correspond to a specific endocrine gland and particular area of the body. One of the
primary functions of the chakras is to vitalize and energize the HEF and physical body.
Energy-based therapies have been developed that allow assessment and manipulation of
the HEF to enhance health and well-being. Healing touch (HT) is an energy-based
therapeutic technique theorized to influence the chakras and human energy field ultimately
to impact physical, psychological, and spiritual health and well-being (Dossey et ai , 1 995).
HT is theorized to elicit effects through an energy exchange between practitioner
and recipient . However, direct measurement of this energy exchange is not currently
possible. Research to date on energy therapies has focused on various indirect measures of
psychological and physiological effects thought to be involved in mind-body interactions.
Psychoneuroimmunology provides a well-studied framework for investigating and
understanding the intricacies and significance of the relationship between the mind and the
body. In this research, the PNI conceptual framework was used as the foundation for a
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clinical trial examining the effects of HT on the psychological parameter of well-being; the
neuroendocrine parameters of bioavailable serum serotonin, salivary
dehydroepiandrosterone ( OHEA) and cortisol; and the immunological parameters of
lymphocyte proliferation to phytohemagglutinin (PH A), natural killer (NK) cell activity,
C04+ and C08+IC057+ lymphocyte levels, and selected type 1 and type 2 cytokine levels
in individuals infected with the human immunodeficiency virus (HI V). These parameters
were chosen because of their interrelationships within the PNI framework and the
potential of the interrelationships to affect positively neuroendocrine and immune function
in individuals living with HIV disease. HT was chosen because of its potential to enhance
immune function through its ability to enhance well-being. This study will add to a
growing body of scientific investigations of PNI and energy-based therapies.
Purpose
The purpose of this study was to ascertain the effects of HT on selected PNI
parameters in HIV -infected participants It was hypothesized that HT would increase
participant well-being, which subsequently would increase both serum serotonin and
salivary OHEA, decrease salivary cortisol, and ultimately enhance immune function.
Specific research hypotheses were that HT would (I) enhance well-being, (2) increase
levels of serum serotonin and OHEA, (3 ) decrease levels of salivary cortisol, and (4)
enhance immune function in persons with HIV disease. Ultimately, HT may be beneficial
as part of a comprehensive, integrative program combining allopathic and complementary
therapies to improve the quality of life and survival of persons living with HIV disease.
However, decision-making regarding clinical applicability of energy therapies requires
further scientific evaluation.

4

Conceptual Framework
The conceptual framework for this study is presented schematically in Figure 1 .
Human beings are conceptualized as energetic beings comprised of contiguous, continually
interacting human and environmental energy fields. Energy-based therapies such as HT
allow practitioners to assess and correct imbalances in the energy field to promote health
and well-being. Because PNI encompasses a holistic view of mind-body interactions, it
provides a framework for investigating therapies such as HT that potentially can impact
the interactions among psychological factors such as well-being and neuroendocrine and
immune function
Healing Touch
Brennan ( 1 987) provided a comprehensive history of energetic healing in Hands of
Light A Guide to Healing through the Human Energy Field. Throughout history, in both
the east and west, are descriptions of a universal energy pervading all living things. In
traditional Chinese medicine, it is known as chi. In Ayurvedic medicine, it is called prana.
This energy was first described in the west around 500 BC by the Pythagoreans. This vital
energy manifests itself in human beings as a human energy field (HEF). Since the 1 21h
century, western science, through various techniques including photographic and
electromagnetic procedures, has accumulated evidence to support the presence of a HEF.
Based on observations over the centuries, a theoretical model has been developed
that describes the energy field as being composed of seven layers. The seven layers are
connected to the physical body, to each other, and to universal energy by chakras or
energy vortexes. Disturbances or imbalances in the HEF can be assessed and altered
intentionally through the chakras. As mentioned, each chakra is believed to correspond to
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a specific endocrine gland and particular area of the body. A diagram of the seven major
chakras and their theoriied corresponding endocrine glands and body regions is provided
in Appendix A. Because the chakras are believed to vitalize the body, they are directly
related to health and illness. According to Moore ( 1 997), "the basic premise of most
energy medicine models is that dysfunctions occurring with the chakras translate down
into the physiological level" (p. 47)
HT is an energy-based therapy developed in the 1 980's by Janet Mentgen, based
on earlier work by Kunz and Krieger (Brennan, 1 987). The underlying premise of HT is
consistent with ancient descriptions of the body as a complex energy system whose
physiological functions are influenced by the flow of that energy. Through the use of HT,
it is postulated that a recipient's energy flow can be assessed and balanced. The particular
HT technique used in this trial was the chakra connection, which is used to balance and
connect the major energy centers or chakras. The purpose of the chakra connection is to
restore balance in the human energy field to promote psychological and physiological
health. Eisenberg (1993 ), a western-trained physician and expert in traditional Chinese
medicine, stated that "energy medicine" is in no way inferior to synthetic drugs and other
biomedical therapies, it simply uses a different approach to health and illness However,
well-designed trials are needed to assess the effects of energy-based therapies.
Well-being
For the purpose of this study well-being was a measure of the potential effects of
HT as well as the primary link between HT and PNI . Well-being has been defined as "the
state of being generally healthy, happy, or prosperous" (Riverside Webster's II Dictionary,
1 996, p. 769) . According to Bradburn ( 1 969), well-being is conceptualized as having an
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affective-emotional component as well as a cognitive-judgmental component . Basically, an
individual experiences positive well-being when positively perceived emotions outweigh
negatively perceived emotions, and vice versa. It is not the absolute amount of positive or
negative emotion that determines the affective-emotional aspect of well-being, but the
balance between the two . The cognitive-judgmental component reflects the individual ' s
satisfaction with life. Thus, subjective well-being is the individual' s perception o f the
balance of positive and negative emotions as well as satisfaction with his or her goals in
life and the perceived potential to achieve these goals
Consistent with Bradburn's conception of well-being, Dossey and colleagues
( 1 995 ) defined well-being as a process of increasing awareness of reaching human
potentials According to the Rogerian energetic framework, well-being can be
conceptualized in terms of human field image (HFI). Generally, HFI is an individual
perception of the infinite wholeness of the human field (Johnston, 1 994) Johnston defined
HFI as "one manifestation of the human and environmental patterning process, which may
be expressed as a perception of one's potential and an awareness of one ' s integrality" (p.
8). Perceived potential encompasses concepts related to the perception of the presence or
absence of boundaries, while integrality represents manifestations of the perceived human
environmental mutual process. Thus, well-being can be conceptualized as an individual
perception comprised of physical, psychological, and energetic dimensions encompassing
overall health, positive and negative emotions, as well as the recognized potential for
achieving and maintaining well ness and balance in life.
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Immune Function
The functioning Of the immune system is orchestrated by a variety of cells and
cellular products. Immune cells are collectively identifi e d as leukocytes or white blood
cells (WBC ' s) . WBC ' s are divided into three main categories: lymphocytes, monocytes,
and granulocytes. Functional differences exist among these broad categories with further
distinctions delineated among lymphocyte subpopulations. Lymphocytes are divided into B
cells, T-helper cells, T -suppressor cells, and NK cells. B cells protect against bacterial
infections and produce antibodies. T -helper cells stimulate immunological activities, and
T -suppressor cells down-regulate immune responses. NK cells are non-specific cytotoxic
or cell-killing cells. Unlike other cytotoxic lymphocytes, they do not require prior
sensitization to induce a cytotoxic response. They provide antiviral and antitumor
protection. Because there are so many different cells performing so many different
processes, immune function can be assessed using a variety of approaches. Enumerative
measures assess the number and/or percentage of particular cells. Functional assays assess
processes such as lymphocyte proliferative response to antigens, specific cytotoxic
activities, and the ability to generate humoral regulatory substances such as antibodies and
cytokines (Weisse, 1 992).
HIV Disease
According to Folkman ( 1 993 ), the psychosocial effects of HI V disease cannot be
understood without some basic understanding of HIV disease. HIV is transmitted through
interpersonal sexual contact with an infected individual, exposure to contaminated blood
or blood products, and perinatally from an infected mother to her infant . The physical
course of HIV varies widely. Within several weeks of infection, individuals can develop a
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self-limited acute illness that is similar to mononucleosis, with fever, sore throat, malaise,
skin rash, headache, and lymphadenopathy. Following resolution of this illness, there is
usually an extended incubation or "latent" period, which varies in length from 1 to 1 0
years. During this latent phase, individuals are relatively healthy with periodic symptoms
such as lymphadenopathy, fatigue, low-grade fevers, and other non-specific symptoms.
Some individuals have no physical symptoms or laboratory abnormalities during this time.
The next phase is marked by minor infections such as oral candidiasis, herpes
zoster, and recurrent herpes simplex outbreaks. Other non-specific symptoms that can
occur during this time include fevers, night sweats, weight loss, diarrhea, and skin rashes.
As the disease progresses and cellular immunity becomes more impaired, opportunistic
infections, tumors, neurological disorders, and more severe weight loss (> 1 0% of ideal
body weight) develop. The aforementioned non-specific symptoms usually continue. The
diagnosis of AIDS is established with the occurrence of any of the AIDS-indicator
conditions defined by the Centers for Disease Control and Prevention (CDCP) such as
pneumocystis pneumonia, wasting syndrome, and encephalopathy. HIV medication
regimens are focused on inhibiting viral reproduction, maximizing immune function, and
preventing concurrent infections Because of the extended asymptomatic phase and the
stabilizing effects of medications, HIV is now considered a chronic disease (Folkman,
1 993 ).
PNI
PNI is the study of the complex interactions among behavior and the
neuroendocrine and immune systems. It is considered a holistic framework because it
encompasses these interactions, which were previously conceptualized as separate and
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isolated entities. The field of PNI grew from the realization that the immune system does
not function autonomously. Currently the immune system is perceived as a large sensory
organ providing indirect feedback to the central nervous system (CNS) through messenger
chemicals such as cytokines. The CNS is physically and systemically connected to the
immune system by the autonomic nervous system and neuroendocrine outflow from the
pituitary gland. Sympathetic neurons innervate immune organs including the thymus, bone
marrow, spleen, and lymphatic system. These nerve fibers communicate directly with
immune cells such as lymphocytes. Lymphocytes express soluble mediators for CNS and
neuroendocrine substances, such as hormones and neurotransmitters, and have specific
receptors for such mediators on cell membrane surfaces. The immune system is also
influenced by neuroendocrine outflow from the pituitary Following the release of
stimulating substances from the pituitary, the adrenal cortex produces two steroid
hormones that affect immune function : cortisol and DHEA (Ader, Cohen, & Felten,
1 995 )
Cortisol is the major glucocorticoid produced by humans and potentially the most
important steroid hormone influencing immune function within the context of PNI.
According to Reichlin ( 1 993 ), cortisol, when produced in excess, has the potential to
interfere with virtually all components of the immune response. Cortisol reduces
lymphocyte numbers as well as cellular function (Hillhouse, Kiecolt-Glaser & Glaser,
1 99 1 ; O ' Leary, 1 990; Stein & Miller, 1 993 ). Its immunosuppressive effects are often
related to regulatory interference with cytokines (Clerici, Bevilacqua, Vago, Villa, &
Norbiato, 1 994)
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DHEA is produced in the adrenal cortex and is the most abundant steroid hormone
in the body. Research exploring the physiological role of DHEA confirms its major
regulatory function in the immune system (Regelson, Loria, & Kalimi, 1 994). For
example, Khorram, Vu, and Yen ( 1 997) found that immune function improved
significantly following oral supplementation of DHEA in aged men. Increased numbers of
monocytes, NK cells, and B-lymphocytes, as well as an increase in lymphocyte
proliferation evidenced enhanced immune function.
Psychological modulation of immune function has been investigated in two
primary areas : classical conditioning and the impact of stress. Ader and Cohen ( 1 975,
1 993 ) paired a saccharin solution with cyclophosphamide (a chemotherapy agent) and
demonstrated a conditioning effect on the immune system in the form of significant
immunosuppression when the saccharin solution was given without the
immunosuppressive drug. This discovery was a pivotal finding in the development of the
field of PNI . Solvason, Ghanta, and Hiramoto ( 1 988) also demonstrated conditioned
immune enhancement.
Stressors activate the sympathetic nervous system as well as the hypothalamic
pituitary-adrenal axis, thereby potentially impacting immunity. Although Selye ( 1 95 6)
originally proposed a model of nonspecific responses to various stressors, it is now
accepted that different types and patterns of stressors can produce different patterns of
autonomic responses (Mason, 1 97 1 ) Additionally, individual factors such as personality,
coping styles, and affective states can modulate physiological responses (Friedman &
Booth-Kewley, 1 987; Chesney & Rosenman, 1 983 ; Herbert & Cohen, 1 993 ).
There is increasing evidence that immune processes occur within a neuroendocrine
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environment that is "sensitive to the influence of the individual ' s perception of and
response to events in the external world" (Ader, Cohen, & Felton, 1995, p. 1 00). PNI
provides a framework for conceptualizing and investigating the means by which
psychosocial factors and affective states can influence the development and progression of
immunological diseases.
PNI in HIV Disease
To date, much of the research done in the field of PNI has focused on individuals
with impaired immune function, such as those individuals living with HIV disease, because
even subtle changes in the neuroendocrine and immune systems of these individuals are
potentially helpful in maintaining adequate immune function and health. Cellular immune
reactions are under the regulation of two categories of lymphocytes, T -helper (CD4+) and
T -suppressor (CD8+) cells. The relative numbers and function of these lymphocytes
influence the strength and persistence of immune responses. HIV primarily infects the
CD4+ helper/inducer lymphocyte, a key cell type in regulation of both cell-mediated and
humoral immune responses. Ultimately, HIV destroys CD4+ cells; measurable reductions
in CD4+ lymphocyte counts occur when cell destruction exceeds cell replication. This
decline in CD4+ lymphocytes correlates with HIV disease progression. With disease
progression, in addition to T-lymphocyte functional impairment, NK cell function is also
impaired (Brenner, Dascal, Margolese, & Wainberg, 1 989; Clerici et a1 . , 1 989)
NK cells are part of the host's natural immunity to HIV -associated disorders and
opportunistic infections. In vivo, NK cells play a vital role in fig hting infections by
producing cytokines, such as tumor necrosis factor (TNF)-alpha and interferon (lFN)
gamma, even before T-cell activation occurs. Generally, there is no significant enumerative
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change i n NK cells i n HIV disease. However, NK cell function may be of major prognostic
significance in AIDS pathogenesis. Normally, NK cells spontaneously lyse virally infected
and cancerous cells. However, NK cells become functionally defective as HIV disease
progresses and the cause of this dysfunction remains unknown (Brenner, Dascal,
Margolese, & Wainberg, 1 989; Chehimi et aI , 1 992; Sirianni, Tagliaferri, & Aiuti, 1 990) .
According t o Clerici and Shearer ( 1 993 , 1 994), an immune system imbalance
occurs in HIV disease that further weakens the immune system and accelerates the
progression to AID S . They proposed a shift from type 1 to type 2 cytokine regulation as a
critical step in the progression of HIV infection. Cytokines may be an immunologic marker
of HIV disease progression Increased levels of soluble cytokine receptors in HIV-infected
individuals are associated with a chronic state of cellular activation that is an important
part of the pathogenesis of HIV disease. According to Poli and Fauci ( 1 996), this ongoing
immune activation likely contributes to a state of persistent HIV replication, underlying a
vicious cycle of activation and virus replication that fosters the progression of HIV
disease.
Cytokines are proteins that function through intercellular receptor binding. They
regulate immune system functioning including cellular and humoral immune responses.
Cytokines are known to be behaviorally, endocrinologically, immunologically, and
electrophysiologically active (Ader, Cohen, & Felton, 1 995 ). The cellular and humoral
arms of the immune system tend to counteract each other by cytokine regulation. Evidence
suggests cytokine response patterns are involved in immunomodulation (Mosmann & Sad,
1 996). Generally, a type 1 cytokine pattern (including interleukin-l [IL-l], IL-2, IL- 1 2,
IFN-gamma, and TNF-alpha) enhances cellular immunity, while a type 2 pattern (including
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IL-4, IL-S, IL-6, IL-9, IL- I 0, and IL- 1 3 ) diminishes cellular immunity and enhances
humoral immunity. Type '1 cytokines stimulate effector responses to viral infection and
other intracellular pathogens through activation of NK cells and cytotoxic lymphocytes.
Type 2 cytokines support effector responses to bacterial and parasitic infections and
mediate allergic responses by promoting antibody production. Cross-regulation exists
between type I and type 2 cytokine responses. For example, IFN-gamma and IL- 1 2
functionally down-regulate type 2 responses and IL-4 and IL- I 0 functionally down
regulate type I responses. Conversely, inhibition of IFN-gamma and IL- 1 2 will augment
type 2 responses and inhibition of IL-4 and IL- I 0 will enhance type I responses (Shearer
& Clerici, 1 992; Clerici & Shearer, 1 993 ; Levy, 1 993 ; Kuby, 1 994). While these

mechanisms are generally exhibited, the exact role of cytokines remains a complex issue.
Depending on the cytokine milieu and/or functional status of an infected cell, IFN-gamma,
IL-4, and IL-l0 can act as positive or negative modulators (Poli & Fauci, 1 996). Shearer
and Clerici ( 1 996) acknowledged that their theory does not take into account the
"interaction of immunoregulatory cytokines produced by the many different cell types
operating in a dynamic and open system" (p. 230)
The progressive dysfunction of the immune system in HIV disease ultimately
results in increased susceptibility to opportunistic infections and the clinical syndrome of
AIDS . However, the clinical course of HI V is highly variable with or without treatment .
The variability in the clinical and biological course of HIV may be due solely to properties
of the virus itself, although it is most likely that environmental and/or host cofactors also
influence disease progression (Kemeny, 1 994). Although the relationships among behavior
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and mood, immune function, and HIV disease progression are not yet clear, there is
reason to believe these relationships exist (Schneiderman, 1 994).
In a review of stressful events, psychological responses, and progression of HIV
disease, Kemeny ( 1 994) cited multiple physiological and psychological cofactors for HIV
disease progression, including substance abuse, malnutrition, sexually transmitted diseases,
the presence of other viral infections, and negative affective states such as dysphoria,
bereavement, fatalistic thinking, and hopelessness. Currently, there is little empirical
support for the relationship between psychological well-being and immune function.
However, stress and coping effectiveness are considered cofactors for HIV disease
progression and there is significant empirical support for a relationship between stress and
psychological distress, or the individual ' s reaction to stress, and HIV disease progression
(McCain & Zeller, 1 996) Similar mechanisms may be responsible for the relationship
between dysphoric or negative affective states and immunosuppression (Herbert & Cohen,
1 993 ) Additionally, the relationship between stress and immune function is mediated, in
part, by an individual's perception of potentially stressful events. Similarly, an individual ' s
mood could potentially mediate immune function. Whereas a negative affective state may
diminish immune function, a positive affective state may enhance immune function. In a
comprehensive review of studies involving PNI and HIV disease, McCain and Zeller
( 1 996) concluded that because of the paucity of studies of well-being as well as design and
validity problems, there is currently little empirical support for relationships between well
being and immunity. They proposed two research priorities (a) investigating the
effectiveness of nursing interventions in HIV disease, and (b) identification of
biobehavioral factors and testing interventions that foster immunocompetence. This
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clinical trial contributes t o the developing knowledge base o f the effectiveness of the
biobehavioral intervention of HT in fostering immunocompetence in individuals living with
HIV disease. It was proposed that HT may enhance well-being because of its potential to
elicit the relaxation response and decrease anxiety and physical discomfort. It is
conceivable that interventions, such as HT, that enhance well-being and possibly neurally
mediated immune function, may enhance quality of life as well as retard HIV disease
progression. This trial was needed to investigate the host cofactor of well-being, a global
indicator of an individual ' s perception of their day-to-day life and long-term aspirations,
and its possible effects on the neuroendocrine environment and immune function in
individuals living with HIV disease
In summary, PNI provides a holistic framework for examining interactions among
psychological states and the neuroendocrine and immune systems. This framework is
particularly applicable in immunologically mediated diseases such as HIV disease. PNI
research in HIV disease has focused primarily on the impact of stress and negative
affective states on disease progression, while the potential impact of positive affect
remains largely unexplored. HT and other energy therapies are theorized to focus on
healing at the quantum and electromagnetic levels in individuals. These therapies are also
associated with the elicitation of the relaxation response. Generally, these therapies have
the potential to enhance well-being in a variety of ways, although the exact mechanisms of
action are not yet known. In this research, PNI serves as an organizing paradigm for
investigating the effects of HT on well-being in individuals living with HIV disease. It was
specifically proposed that HT had the potential to improve well-being, thereby eliciting
favorable changes in the neuroendocrine environment and ultimately enhancing immune
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function Despite the complexity o f investigating immune function i n the presence of
somewhat unpredictable and often inadequately understood immune dysfunction, if even
subtle effects of HT on neuroendocrine and immune function are detected, their impact
may be clinically significant in individuals with impaired immune function. This trial sought
to examine the effects of HT on well-being and ultimately immune function, but because it
was not a longitudinal study, it provided only theoretical conclusions about health
outcomes.
Significance
P NI provides a comprehensive conceptual framework for investigating the
relationship between the mind and the body as well as interventions that may influence this
relationship. Research indicates that stress and its correlate, psychological distress, can
alter immune function, thereby influencing disease susceptibility (McCain & Smith, 1 994)
However, investigations into the clinical applicability of mind-body interventions for
promoting health and treating disease are limited (Zeller, McCain, & Swanson, 1 996). The
research that does exist focuses on the impact of distress or negative affect, while the
effects of positive affect or subjective well-being have been largely unexplored. It is
theoretically sound to propose that if negative affect can impair immune function, then
positive affect may enhance immune function. In individuals whose immune function is
impaired, as is the case in individuals living with HIV disease, even subtle changes in
immune function could affect health. This clinical trial provided valuable insights into the
the effect of HT using a P NI paradigm.

Figure

1.

Conceptual Framework: Psychoneuroimmunology and Healing Touch in HIV Disease

Chapter 2
Review of Research
The components of the research review are structured according to the purpose of
this clinical trial, the investigation of the effects of HT on well-being , the neuroendocrine
environment, and immune function in individuals living with HIV disease. The review is
representative of the applicable research that exists in the areas of energy therapies, well
being, the interactions among the neuroendocrine and immune systems, immune
dysfunction in HIV disease, and the field of PNI in HIV disease.
Healing Touch
Only two studies evaluating the effects of HT were found in peer reviewed
journals. In an anecdotal case study, HT was shown to facilitate healing of a cesarean
wound infection (Wetzel, 1 993 ). HT was performed every other day for 1 2 days (from
postoperative day 8 through 1 9), then on postoperative days 25, 3 1 , and 47. Generally,
the treatment consisted of magnetic unruffiing followed by the conscious direction of
energy into the wound. This patient also received standard wound care, including oral
antibiotics and wound irrigation and dressing changes three times a day while the open
wound healed by second intention. Other patients who had wound infections during the
same time period as the patient in the case study had taken 9 to 1 6 weeks to heal.
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Wetzel reported the patient treated with HT had a similar wound but was fully healed i n 6
weeks. However, the lack ·of research controls for this study obviated meaningful
compansons.
In the other study, HT was shown to decrease postoperative pain. Silva ( 1 996)
assessed the effects of HT on postoperative pain, relaxation levels, and physiological
functioning in a sample of 60 women who had abdominal hysterectomies. Participants
were assigned randomly to one of three groups HT, back massage, or no treatment. Each
group consisted of 20 participants. The treatment group received a 20-minute HT
intervention while one control group received a 20-minute back massage and the other
control group received standard postoperative care on the day of surgery and 24 and 48
hours after surgery. A nursing assessment, including vital signs, and activity level as well
as lung, gastrointestinal, urinary, and motor function, was performed before and after each
session and on the third postoperative day. The amount of self-administered narcotic
analgesia and the number of medications and treatments to stimulate bowel function were
recorded daily. Data were analyzed using repeated measures analysis of variance and
analysis of covariance. Participants who received HT experienced a higher level of
recovery as evidenced by more rapidly improved lung and gastrointestinal function as well
as higher activity levels when compared to the back massage and control groups. The HT
group also experienced statistically significant reductions in systolic and diastolic blood
pressure and pulse rates. Additionally, the HT group received significantly less narcotic
analgesia and fewer bowel treatments compared to the other groups.
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I n a doctoral dissertation published i n Dissertation Abstracts International, Slater
( 1 996) investigated the effects of HT on chronic non-malignant abdominal pain in 23
participants who had a history of abdominal surgery. Each participant received three
different treatments on separate days HT administered by experienced practitioners, HT
administered by inexperienced or "naive" practitioners, and an interview. The order of the
treatments was randomly assigned . The treatments given by the experienced and
inexperienced practitioners were identical, consisting of the HT techniques of magnetic
unruffiing and wound sealing. The interview was used as a placebo control to assess
whether HT elicited a greater response than did a nurse being and talking with a patient in
pain. Pain perception was measured before and after treatments using the McGill-Melzack
Pain Questionnaire (MMPQ). Additionally, qualitative data exploring the practitioners'
and recipients' experiences were collected then analyzed using content analysis. There
were no significant differences in pain perception as measured by the MMPQ following
either of the HT sessions. Inexperienced practitioners experienced more physical
discomfort during sessions than did the experienced providers. Interestingly, the recipients
preferred the inexperienced practitioners because the recipients experienced more nausea,
headaches, dizziness, and drowsiness with the experienced practitioners. However,
participants subjectively reported greater pain relief and relaxation following treatments
with experienced HT practitioners despite the increase in other symptomatology. The
author proposed this may indicate that the MMPQ differentiates between dimensions of
pain, but that individuals experiencing pain may evaluate their pain based on criteria other
than pain sensations. In this investigation, HT did not decrease postoperative pain
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significantly. The effect of the therapeutic interview on pain levels was not mentioned in
the abstract . The small sample size may have contributed to the lack of statistical
significance.
Healing Touch International publishes an annual survey of HT research containing
information on upcoming, ongoing, and completed research. The survey includes abstracts
of the completed HT research. Several of these studies are applicable to this research and
therefore are included in this review of the literature. Some of these studies were recently
completed and publications are in process. However, the majority of them are not being
published in professional journals. Although the studies provide some potentially valuable
information about the experience and effects of HT, they generally lack adequate
methodological rigor.
DuBrey ( 1 998 ) explored perceived effectiveness of HT treatments in a
convenience sample of 25 individuals visiting a rural wellness center. The participants
were ambulatory patients visiting a community-based well ness center; however their health
status was not mentioned in the abstract . Following a single HT session, individuals were
asked to rate pain perception, stress perception, and emotional well-being on a 1 to 1 0
scale, with 1 being the least change and 1 0 being the greatest . Participants were asked to
document the lasting effectiveness of treatment at 1 to 3 days, 4 to 7 days, 1 to 2 weeks,
and greater than 2 weeks. None of the participants experienced an increase in pain or
stress or a decrease in well-being following treatment . A total of 92% (n=2 3 ) experienced
decreased stress following HT, 68% (n= 1 7) experienced decreased pain, and 88% (n=22)
experienced an increase in well-being. The reduction in stress levels persisted for up to 3
days in 3 6% of participants, up to 7 days in 20%, up to 2 weeks in 1 1 %, and greater than
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2 weeks in 28% of participants. Pain reduction was sustained for up to 3 days in 3 3 % of
participants following heali·ng touch, up to 7 days in 28%, up to 2 weeks in 1 1 %, and
greater than 2 weeks in 28% of the participants. Increased levels of emotional well-being
persisted for up to 3 days in 1 2% of the participants, up to 7 days in 3 2%, up to 2 weeks
in 1 6%, and greater than 2 weeks in 40% of participants following HT. The researcher
concluded that 88% of individuals reported a significant increase in their feelings of
emotional well-being and 40% of those individuals experienced increased well-being that
persisted for more than 2 weeks. Caution is required when interpreting the findings of this
study because there was no control group and all measures were highly subjective and
vulnerable to reactivity.
One investigator examined the effects of HT on depression. Leb ( 1 998 ) recruited
30 individuals with moderate to severe depression, as measured by the Beck Depression
Inventory, then randomized them into treatment and no treatment control groups. The
treatment group received HT twice a week for 3 weeks. They received the same treatment
each week, consisting of centering, chakra spread (to open the energy field), magnetic
unruftling (to clear any debris or imbalance in the field), modified mind clearing (to
balance neurochemicals), seventh chakra spread (to clear the individual/universal
connection), and terminating the session. The participants who received HT were
significantly less depressed at the end of the 3-week intervention as compared to the
control group who received no HT treatment . Depression levels were assessed one month
later and the treatment group continued to demonstrate lower levels of depression
compared to baseline. Information about the equivalence of groups at baseline was not
addressed. No alternate explanations were offered for the improvement in the treatment
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group such as social support, medications, or psychotherapy. Additionally, these variables
were not addressed as pote · n tial confounders.
One qualitative investigator explored the subjective experience of the chakra
connection, the HT technique proposed in this trial . Moreland ( 1 998), in a
phenomenological inquiry, asked six women who were undergoing intravenous
chemotherapy for breast cancer to describe the experience of receiving HT with as much
detail as possible. Three primary themes were identified. The experience was perceived as
(a) caring expressed as a partnership, a nurturing act, and as self-care; (b) creating altered
consciousness of the passage of time, the surrounding environment, of thought, and of the
presence of the practitioner; and (c) a holistic experience involving physical,
mental/emotional, and spiritual dimensions. The author concluded that HT for this group
of participants was a "holistic, caring, and variable experience which altered their
perception of self, time, and their surrounding environment in a positive way. This helped
them 'get through' the experience of the chemotherapy" (p. 1 1 ) This was a well-designed
and conducted phenomenological inquiry providing insight into the experience of receiving
HT, but because of its qualitative design the findings cannot be generalized to other
practitioners and recipients.
Wilkinson ( 1 998) is currently conducting a three-phase study focused on
understanding the effects of energetic healing. Phase 1 of the research was a qualitative
exploration into the experience of receiving HT and has been completed. Phases 2 and 3
are in progress. Phase 2 is quantitative and involves laboratory analysis of salivary IgA
concentrations before and after HI. Phase 3 will involve integrating Phases 1 and 2. In
Phase 1 , the researcher interviewed 1 2 HT practitioners and 7 HT recipients about the
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experience of HT. The inquiry involved details about the experience, whether or not HT
promoted health and personal growth, and from the recipients' perspectives, which
elements of HT were perceived to be the most effective. Following content analysis, five
themes were identified : changes, relaxation, an awareness of process, practitioner
deliberateness, and heightened holistic awareness. All recipients except one reported
positive changes following HT. The perceptions of the recipient whose experiences were
unfavorable were not described in the Healing Touch International report. Relaxation,
physical touch, and energy exchange were the answers given most frequently when
recipients were asked which elements of HT they found most beneficial Details about the
practitioners' responses were not included in the research abstract. Once again,
information about the experience of receiving HT is provided which may infuse meaning
when interpreting the psychophysiological responses to HT. However, data generation and
analysis procedures and issues related to rigor and t rustworthiness were not addressed in
the abstract .
Included in the HT survey was a brief report regarding data informally collected by
Lorene spanning greater than 3 00 hours of work with HI V-seropositive clients in her
capacity as a volunteer at the Holistic AIDS Response Program at the University of
California at San Diego. Because the sample was comprised of HIV -seropositive
individuals treated with the chakra connection, this research is included here as reported
through personal communication with the researcher. During I -hour HT sessions, the
researcher performed magnetic unruffiing, chakra connection, and a modified brain
balance technique. Clients were typically dealing with symptoms related to pain or
agitation or both. In clients experiencing pain, pre- and post-treatment evaluations of pain
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were completed using a 1 - 1 0 scale, with 1 being "minimal pain" and 1 0 being "the worst
pain ever." Responses in the 8-9 range consistently dropped to 0 by the end of the HT
session. To assess agitation, clients' verbal responses were assessed before and after HT.
Subjective reports consistently demonstrated considerable agitation or anxiety pre
treatment and feeling calm and relaxed post-treatment . Lorene stated that HT is part of
routine HIV -related care at the holistic center because the outcomes are so positive (10
Lorene, personal communication, November 1 3 , 1 998). These data provide interesting
anecdotal information about the effects of HT in individuals living with HIV disease.
However, it does not provide sufficiently rigorous scientific information about the effects
of HT in HIV disease.
Therapeutic Touch Research
Because there are limited peer-reviewed HT publications and HT and therapeutic
touch (TT) are related energy-based therapies, a review of TT research is also included.
Krieger and Kunz, a nurse and a healer, developed TT in the 1 970's. Its origins are based
on the ancient technique of laying on of hands, traditional eastern medicine, as well as
quantum physics (The Burton Goldberg Group, 1 995 ; Castleman, 1 996) . Generally, the
practitioner does not physically touch the recipient during TT. The hands are placed 2 to 6
inches away from the body. HT is a comprehensive framework of energy-based therapies
which subsumes the technique of TT. HT was developed after the introduction of TT into
nursing practice and literature. It shares the same theoretical basis but is comprised of a
wider variety of techniques (involving both physical touch as well as working 2 to 6 inches
away from the body) specific to particular energy imbalances or physical illnesses and
involves a longer, more complex certification process. According to Slater ( 1 995 ), who
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developed a theory of energetic healing based on physics, energetic healing is healing that
occurs at the quantum and 'electromagnetic levels of an individual . According to this
theory, all energy therapies are based in the laws of physics and, fundamentally, all are
varying techniques that elicit similar effects.
Therapeutic touch and the relaxation response. TT has been shown to induce a
generalized relaxation state. As described by Krieger and colleagues ( 1 979), this response
included dilation of the vessels of the skin, decreased vocal pitch, and a subjective feeling
of tranquility in clients undergoing TT. The most interesting finding in this small
experiment were the electroencephalogram (EEG) findings. Generally, when the eyes are
closed and a person is in a calm state of mind, an alpha state exists. A normal state of
wakeful awareness is a beta state. The participants exhibited alpha wave activity on EEG
even though their eyes were open. When questioned, they expressed a sense of well-being.
Despite the intriguing results of this report, there were only three participants and no form
of scientific control was applied.
Based on the premise that a TT encounter affects both the recipient and the
practitioner, a more recent study evaluated the presence of the relaxation response in
nurses performing TT (Sies, 1 994). The researcher recruited eight nurses who had been
practicing TT for at least one year and measured peripheral skin temperature while they
performed TT for at least 1 5 minutes. Sies found that 50% of the practitioners
demonstrated a relaxation response as evidenced by increased peripheral skin temperature.
The personal practice of meditation or other relaxing therapies was not assessed or
controlled in the practitioners. Furthermore, half of the practitioners did not demonstrate a
significant relaxation response.
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TT and hemoglobin. Extensive work has been done on the physiological and
psychological effects of TT since it was introduced by Krieger in 1 974 (Quinn, 1 988).
Krieger ( 1 975) demonstrated a significant increase in hemoglobin levels in hospitalized
adults following TT. A convenience sample of 64 patients was treated with either TT or
routine nursing care. There were no significant differences among baseline hemoglobin
levels. Despite a reported increase in mean hemoglobin levels, rigor was lacking in this
early trial . There were no operational definitions or randomization procedures and
hemoglobin values were not included in the report .
TT and pain. Several trials have shown TT to decrease pain. In a quasi
experimental trial, Keller and Bzdek ( 1 986) investigated the effects of TT on tension
headache pain. Based on the premise that TT reduces anxiety and given there is an anxiety
component in tension headaches, a sample of 60 healthy participants with tension
headaches was randomly assigned to the TT intervention or a mimic TT control group.
Each participant received a 5-minute intervention. The researchers did TT sessions and
data collection. In the TT group, the researcher centered and entered a quiet meditative
state, making a conscious intent to help the recipient . In the mimic TT control group,
there was no attempt to center or reach a meditative state. The researcher performed the
same movements as with the TT group while focusing on the mental task of subtracting
from 1 00 by 7s. Pain levels were measured immediately prior to the intervention and 5
minutes and 4 hours after the intervention using three subscales of the McGill-Melzack
Pain Questionnaire. A Wilcoxon signed-rank test for differences revealed that 90% of the
participants exposed to TT reported a sustained reduction in headache pain. The TT group
experienced twice the amount of pain relief at 4 hours when compared to the control
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group. The control group also experienced some headache pain relief, perhaps validating
potential placebo or Hawthorne effects. This study included an adequate sample size and
randomization to groups. However, statistical analysis was weak and the study design did
not address potential covariates. Additionally, the researcher administered the treatments
as well as the pain questionnaires, allowing for signifi cant practitioner-participant effects.
Finally, even though the practitioner consciously attempted to block any intention to help
or direct energy during the mimic sessions, the effect of a caring presence cannot be
excluded, especially in light of a decrease in headache pain in the control group. To this
researcher, the TT mimic or sham control is an inadequate control condition, primarily
because of the presence of a caring individual . The majority of the individuals performing
the mimic sessions are nurses and although they are not trained in TT, they represent
caring presence, rendering attribution of any detectable effects to TT difficult . Assessing
the effects of energy therapies is at best complicated, even when controlling for
confounding variables that potentially affect the dependent variable of interest .
Additionally, the mechanism of action of energy therapies remains unknown. If it is actual
energy exchange or modulation, this cannot currently be measured adequately. A no
treatment control group is a better alternative because it removes the possibility of effects
related to therapeutic human contact .
Meehan ( 1 993 ) studied the effects of TT on postoperative pain in 1 08 individuals
following major elective abdominal or pelvic surgery. Individuals were randomized into
three groups: TT intervention, mimic TT intervention (MTT), and the standard
intervention (SI) of analgesic medication as needed (PRN). Pain levels were measured
using the Pain Visual Analogue Scale (V AS) before and one hour after the assigned

28

intervention. The author identified the V AS as a widely recognized, valid and reliable tool
for measuring acute pain. Validity of the V AS was assessed in this study by correlating
participants' verbal pain intensity descriptors with their V AS scores. The descriptors were
"no pain," "mild pain," "moderate pain," "severe pain," and "pain as bad as can be."
The overall descriptor-VAS correlation was . 72. If individuals receiving TT or MTT
requested pain medication, they were assigned a post-intervention pain score equal to their
pre-intervention score for the purpose of statistical analysis. Using analysis of covariance,
the SI group was found to have statistically significant reductions in pain. The TT group
also experienced a decrease in pain but not equal to the level of reduction in the SI group.
The MTT group did not experience any decrease in pain following their intervention. The
participants who received TT did wait a significantly longer period of time in requesting
additional PRN analgesia when compared with the MTT group. The authors concluded
that TT is a useful adjunct to P RN analgesia for postoperative pain but should not be
relied on exclusively for effective pain control. Adequate sample size, randomization
procedures, consideration of covariates, and the researcher not playing the role of
practitioner were strengths of this clinical trial. The use of a visual analogue scale and the
use of a mimic TT control group were weaknesses of the study.
Peck ( 1 997) investigated the effects of TT on pain and distress related to
degenerative arthritis (rheumatoid or osteoarthritis) in 82 elders. Participants served as
their own controls for a 4-week baseline period while receiving routine arthritis care
consisting of medications, heat or cold applications, prescribed rest or exercise, physical
therapy, chiropractic therapy, massage, and steroid injections. Following the 4-week
baseline period, the participants were assigned randomly to receive one TT or progressive
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muscle relaxation (PMR) session weekly for 6 weeks. Additionally, participants were
assigned randomly to practitioners to "control for the differences in personality and
interaction style of the practitioners" (p. 1 2 ). The author chose PMR as the comparison to
avoid the limitations associated with TT sham or mimic controls. The limitations of sham
therapy identified were nurses' anxiety related to consciously withholding a therapeutic
treatment and a placebo effect transmitted by the nurse during a sham treatment. A total of
45 participants received TT while 37 received PMR Two visual analogue scales were
used to measure pain and distress before and after each session. The scales consisted of
I O-centimeter (cm) vertical lines, with the pain scale ranging from "no pain" to "worst

pain imaginable" and the distress scale ranging from "doesn't bother me" to "unbearable."
There were statistically significant reductions in pain and distress in both groups, with the
greatest reductions being in the PMR group . Additionally, there were clinically significant
improvements in the participants' physical abilities during the study. Participants reported
the ability to perform activities they had not been able to perform as well as increased ease
in performing routine daily activities. TT was not as effective as PMR in decreasing
arthritis pain, perhaps because of the therapeutic use of the muscles in PMR or because
TT does not elicit as deep a relaxation response. This study included an adequate sample
size, randomization procedures, and a researcher who did not administer TT treatments.
Limitations include the use of visual analogue scales as the only measure of pain and
distress and possibly random assignment of participants to practitioners. Random
assignment of practitioners to control for practitioner effects is reasonable theoretically,
but it differs from the usual practice of TT. The scientific benefits of randomization may
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not outweigh the benefits of assessing TT in the context in which it is generally given and
received in practice, i.e., by a given practitioner over time.
TT and wound healing. Wirth has conducted a series of studies on the effects of
TT on the rate of wound healing. Following is a study representative of his work. In 1 992,
he investigated the effects of TT on the rate of healing of skin punch biopsy wounds in 44
healthy college students randomized into treatment and no treatment groups. A physician
measured wound size on days 0, 8, and 1 6 using a standard direct tracing method and
digitization system. Wounds were dressed and treated identically in both groups. The
participants were exposed to daily 5-minute TT or mimic control sessions. The group
treated with TT experienced significant acceleration of wound healing at days 8 and 1 6, as
evidenced by decreased wound surface areas as compared to those in the control group.
Adequate sample size, randomization to groups, and independent physician wound
measurement are all methodological strengths in this as well as similar studies done by
Wirth that have yielded similar results. The use of mimic TT in the control group would
not appear to be a concern with the more objective and non-reactive outcome of wound
healing.
TT and anxiety. In multiple studies, TT has been shown to decrease anxiety (e.g.,
Heidt, 1 98 1 ; Quinn, 1 984, 1 989; Simington & Laing, 1 993 ; Gagne & Toye, 1 994; Olson
& Sneed, 1 995 ). Heidt ( 1 98 1 ) measured the effects of therapeutic touch on anxiety in 90

patients hospitalized in a cardiovascular unit of a large urban medical center. An
experimental pretest-posttest design was used with participants randomized into three
groups consisting of S-minute sessions of TT, casual touch, or no touch. The Speilberger
Self-Evaluation Questionnaire, a well-established measure of state anxiety was used,
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although the reliability and validity of this instrument were not reported for Heidt' s study.
Individuals who received TT experienced a statistically significant reduction in state
anxiety. Participants did not experience a significant reduction in anxiety following the
casual touch or no touch sessions. This was a well-designed and executed study. Sufficient
sample size, treatment randomization, a reliable and valid instrument, and appropriate
statistical analysis provided methodological rigor. The researcher did administer the TT
treatments while a research assistant collected data. However, the research assistant was
also responsible for randomization so she was not blinded to group assignments thereby
introducing potential bias
In a related trial, Quinn ( 1 984) found that individuals treated with a form of non
contact TT experienced a greater decrease in state anxiety than did individuals treated
with a mimic control intervention. This was the first TT study to employ the mimic TT
intervention designed by Quinn Quinn was testing the "theorem that the effects of
therapeutic touch do not depend on actual physical contact" (p. 42). This hypothesis was
based on Martha Rogers' nursing theory, the Science of Unitary Human Beings.
According to Rogers ( 1 990), people are energy fields; thus the human energy field is
contiguous with the environmental energy field and physical contact is not necessary for
energy exchanges. Citing Rogers' conceptual system and Heidt ' s ( 1 984) outcome of
anxiety reduction in cardiovascular patients following TT, Quinn conducted an
intervention that "was identical to Heidt ' s intervention except that in Heidt ' s study, the
hands were placed on the subject ' s body" (p. 45). Quinn studied 60 males and females
with cardiovascular disease in an urban medical center. Participants were randomized into
the non-contact TT intervention group or the mimic intervention control group, which
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consisted o f the practitioner performing the same hand movements a s TT practitioners but
without attempts to center, assist the participants, attune to the condition of the
participant, or direct energy. Following a 5-minute session, the individuals who received
non-contact TT experienced a greater decrease in posttest state anxiety than did those in
the control group. Quinn concluded that because physical contact was not necessary for
TT to reduce anxiety, study findings provided support for Rogers' energetic conceptual
system. Another potential conclusion is that many individuals are uncomfortable with
physical touch, thus, a non-contact intervention would be less anxiety provoking. This
study was based on a sound theoretical framework and included an adequate number of
participants, a reliable and valid measure of state anxiety, and attention to conducting TT
and mimic TT sessions identically. Additionally, the researcher collected data while a total
of four nurses administered the TT and mimic TT sessions. The nurses who administered
the mimic sessions had no prior knowledge or training in TT.
In 1 989, Quinn conducted a second investigation testing the theory of TT as
energy exchange. Quinn hypothesized that if TT was based on energy exchange, eye and
facial contact should not be necessary for manifested effects. This hypothesis was not
supported . A total of 1 53 patients scheduled for next-day open-heart surgery were
randomized to one of three groups: TT, a mimic control intervention (MTT), or no
treatment, each lasting 5-minutes. The MTT was the same procedure used by Quinn in the
aforementioned study. This intervention was judged to be indistinguishable from TT when
observed directly by seven naive observers and 40 naive observers watching a videotape.
During the 5-minute sessions, practitioners were asked to avoid eye and facial contact
with participants. Measures included state anxiety, blood pressure, and pulse. There were
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no statistically significant physiological changes among the groups. Decreases in posttest
state anxiety scores were greatest in the TT group but also did not reach statistical
significance. Quinn concluded that eye and facial contact may be a necessary catalyst for
energy exchange in TT . The strengths of Quinn ' s 1 984 investigation are also found in this
follow-up study. The question of the mechanism of action of energy therapies such as TT
remains unanswered .
In a double-blind, three-group experimental trial, Simington and Laing ( 1 993 )
found that individuals treated with TT in the form of a back rub experienced significantly
less state anxiety when compared to individuals who received a back rub without TT.
They studied 1 05 institutionalized elders. Because of pilot data and other evidence
suggesting that pretest measures can bias posttest measures, the researcher chose only
posttest measures for this study. Participants were randomly assigned to one of three
groups: receiving TT in the form of a back rub, a back rub without the focusing and intent
of TT, or a back rub done by a nurse with no knowledge of TT. Participants were
unaware of group assignment and were all treated as similarly as possible. The research
team consisted of three individuals. One research assistant, blinded to the interventions,
assisted participants in completing the state anxiety instrument . The other assistant, a
registered nurse with no prior knowledge or training in TT, randomly assigned participants
to groups and performed the back rub in one of the control groups. The investigator, a
registered nurse and TT practitioner, administered the TT treatments as well as the second
control group consisting of a back rub with no intention to center or direct the flow of
energy. No significant baseline differences were found among the groups on key variables.
The mean state anxiety score for the participants who received a back rub with TT was
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significantly lower than the mean scores in the other two groups. This investigation
included a clearly stated theoretical framework, adequate sample size, treatment
randomization, blinding, limited practitioner/participant bias, and a reliable and valid
anxiety instrument . However, equivalence among groups cannot be evaluated without
pretest measures.
Gagne and T oye ( 1 994) studied the effects of TT and relaxation therapy (RT) on
anxiety reduction. A group of 3 1 hospitalized psychiatric patients were randomly assigned
to one of two treatment conditions, TT or RT, or to the mimic TT placebo condition
designed by Quinn ( 1 984). Participants were treated with two sessions in a 24-hour
period. TT and mimic control sessions lasted 1 5 minutes and were administered by a nurse
or nursing assistant . The RT intervention lasted 25 to 30 minutes and was administered by
a chaplain, according to a commonly used technique developed by Benson. Measures
included experienced anxiety (measured by the State-Trait Anxiety Inventory), a 3 0second frequency count of extraneous physical movement counted by research-trained
nursing staff, and a 1 0-item questionnaire entitled, "Final Summary," assessing the
participant ' s confidence in the treatment and the practitioner. Average pre-treatment
expectation of a positive outcome did not differ among the three groups. Using
multivariate analysis of variance, a significant reduction in experienced anxiety was found
in both the TT and RT groups, but not in the control group . The authors concluded that
larger scientific trials are needed before TT should be used in routine in-patient psychiatric
care, but the study provides evidence of the potential of both TT and RT to
decrease anxiety in this population. This study was well designed including adequate
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sample size, treatment randomization, attention to practitioner-participant interaction
effects, and consideration of covariates.
Olson and Sneed ( 1 995) conducted a four-group, repeated measures experimental
trial investigating the effects of TT on anxiety in 40 healthy professional caregivers who
were enrolled in university-based nursing or health-related graduate programs. The
participants were divided into high- and low-anxiety groups and further into TT or no
treatment control groups. The effectiveness of TT in reducing anxiety as well as the
assessment of concurrent validity of three measures of anxiety were the foci of this study.
Anxiety was measured using two well-established anxiety measures as well as a visual
analogue scale. The three psychometric measures (Profile of Mood States, Spielberger' s
State/Trait Anxiety Inventory, and a visual analogue scale) were highly correlated, but
there were no statistically significant findings related to the effect of TT. No significant
differences were found between the treatment and control groups; however, subgroup
sizes were too small increasing the possibility of a Type I error.
TT and stress response. The effect of TT on stress reactivity has been examined in
at least two trials. In a double-blind clinical trial, Randolph ( 1 984) assessed the
physiological response to stressful stimuli following TT in 60 healthy female college
students. The physiological response was measured by skin conductance level,
electromyography for muscle tone, and skin temperature. Participants were randomly
assigned to receive non-contact TT or physical touch. Baseline measures were obtained on
all participants, then they all watched a 1 3 -minute stressful film while the experimental
group received TT and the control group received physical touch in the form of a nurse' s
hands o n the participant ' s lower back and abdomen. Those nurses performing T T centered
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and attuned to the participants with the intention of therapeutically assisting the
participant, while those nurses performing physical touch simply touched the participants
on the lower back and abdomen. The nurses administering physical touch were not trained
in TT techniques. Physiological response was measured again 8 minutes into the film at its
most stressful point . Following the determination of baseline equivalence between the two
groups, the hypotheses of the study were tested with analysis of covariance using baseline
levels as covariates. None of the hypotheses were supported. The two groups were
physiologically similar at baseline and both experienced significant stress in response to the
film that was not attenuated by either of the interventions. Once again, this was a well
designed investigation that did not demonstrate a significant effect of TT (or physical
touch) on anxiety levels.
Kramer ( 1 990) examined the effect of TT on the stress response in children. A
sample of 3 0 hospitalized children aged 2 weeks to 2 years were "selected" over a 5month period and treated with either TT or casual touch. Randomization was not
mentioned in the published report . Physiological response was assessed using a tool
developed by the researcher for this investigation entitled "Physiological Measure of
Relaxation in Response to Touch ( PMRR T)," comprised of pulse, peripheral skin
temperature, and galvanic skin response measurements. The intervention was done when
the parent was not present, usually between the hours of 6 a.m. and 2 p . m. During a
stressful procedure, children were treated with either TT, including centering and
intending to influence the energy field, or casual touch consisting of stroking or patting the
child's head, torso, or upper arms for 6 minutes. The PMRTT was administered 3 minutes
and 6 minutes into the two interventions. The authors concluded TT significantly reduced
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children' s distress following stressful experiences, as evidenced by more rapid and greater
decreases in scores on the PMRTT in the children who received TT as compared to those
who received casual touch. Findings of this study must be interpreted with caution
because this was not a well-controlled trial . Sample size and treatment randomization were
not mentioned in the published report . Reliability and validity of the PMRTT were not
mentioned . Also, the researcher administered the treatments and collected the data,
possibly introducing bias.
TT and the grief response. At least two studies have investigated the effects of TT
on the grief response. Quinn and Strelkaskaus ( 1 993 ) investigated the effect of TT on
bereavement . This particular study also investigated the effect of TT on immune function
and will be discussed in detail in a subsequent section. In a doctoral dissertation, Robinson
( 1 995) investigated the effects of TT on the grief experience in a convenience sample of
22 recently bereaved adults. This investigation was based on the premise that grief
adversely affects physical and mental well-being and perhaps TT could attenuate these
effects. Participants were randomly assigned to receive either TT or sham (mimic) TT.
Each group consisted of 1 1 individuals who received three consecutive sessions. The time
frame for the TT sessions was not reported . Additionally, it was not clear whether the
researcher administered the TT and sham TT sessions. The Grief Experience Inventory
(GEl) was used to assess the grief experience, but information on the reliability and
validity of this instrument were not included in the abstract . Data were collected prior to
the first session and following the third session, as well as at I -week and 9-weeks
following the interventions. Participants were also asked to describe their perceptions of
the effects of TT on the grief experience at 9-weeks. Descriptive statistics, repeated
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measures analysis of variance, and a summary of subjective responses were used to
analyze the data. The participants who received TT experienced more favorable effects
compared to controls on their grief processes, as evidenced by improved scores on the
GEl as well as verbal reports of improvement in their grief responses. The author
concluded that TT had a benefi c ial effect on the grief experience, but investigator bias
cannot be ruled out in this study.
Qualitative explorations into TT. Three qualitative inquiries exploring the
subjective experience of TT have been published in the literature. The knowledge gained
in these explorations provides insight into the effects of TT as experienced by both the
practitioners and recipients. Additionally, qualitative explorations, while not providing
generalizable results, do provide information for theoretical consideration when
interpreting data in similar populations as well as directions for future research. Heidt
( 1 990) used the constant comparative method to generate a grounded theory explaining
the experience of TT for seven nurse-recipient dyads. The researcher observed and made
extensive notes during one TT session, then interviewed each nurse and recipient about
their experiences. The findings were characterized by consistent descriptions of
interviewees opening themselves up to the flow of universal life energy. There were three
major categories of experiences: (a) opening intent, or allowing oneself to focus on
reestablishing the movement of universal life energy; (b) opening sensitivity, involving
assessing the quality of energy flow; and (c) opening communication, or participating in a
healing relationship that "unblocks, engages, and enlivens" one ' s energy flow (p. 1 80).
Samarel ( 1 992) conducted a phenomenological investigation into the experience of
receiving TT. Data were generated through one unstructured interview followed by a
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second clarifying interview of 20 individuals who had received TT. The participants'
descriptions fell into three time-related categories: experiences before TT treatment,
experiences during TT treatment, and experiences after TT treatment . Each category
contained specifi c elements. Prior to TT, participants described physiological needs,
mental/emotional needs, and spiritual needs. During TT treatment, participants described
self-awareness and other-awareness consisting of altered perceptions related to themselves
as well as others. Following TT, participants described personal changes that lead to
fulfillment in the physiological, mental/emotional, and spiritual realms. According to the
author, "the lived experience of TT was described as a linear process initiated by the
participant ' s decision to seek treatment" (p.6S I ). The process continued through one or
more treatments and continued to make a difference in the participant ' s lives. TT was
experienced as a multi-dimensional process that fostered personal growth and well-being
over time.
Sneed and colleagues ( 1 997) interviewed I I female graduate students after the
second of two TT sessions. During data analysis, five categories emerged that described
the lived experience of the recipients who had no prior experience receiving TT. The five
categories were relaxation, physical sensations, cognitive activity, emotions, and
spiritual/transcendent experiences. All participants reported being relaxed and
experiencing physical sensations and cognitive activity during the TT sessions. Physical
sensations included "warmth", "goose bumps," and "tingling," among others. Cognitively,
participants thought about the process of TT and what was occurring while their eyes
were closed. A few participants expressed emotional or spiritual experiences. Participants
generally reported feeling "good" or "wonderful," but one participant reported feeling
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uncomfortable being the focus of such intense attention. Four participants described
spiritual or transcendent experiences such as feeling more centered . The authors theorized
that perhaps "the sensations associated with TT may occur developmentally," with deeper
experiences occurring when a recipient becomes more familiar with TT (p. 243 ).
The qualitative explorations done by Heidt ( 1 990) and Samarel ( 1 992) were
appropriately designed qualitative studies with attention to rigor and trustworthiness of
the data and findings. These explorations provide insight into the experience of giving and
receiving TT. The third exploration involved interviews by the TT practitioner, followed
by content analysis. The third study lacked adequate rigor and must be viewed with
caution.
TT and well-being In a time-series design, Giasson and Bouchard ( 1 998)
examined the effect of TT on well-being in 20 individuals with terminal cancer hospitalized
in a university-affiliated hospital for palliative care. Participants were assigned randomly to
either a TT intervention group or a control group . The 1 0 participants in the treatment
group received TT on three consecutive days while the control group experienced periods
of rest for the same duration as the TT session ( I S-minutes) at the same time of day.
During periods of rest, the researcher was present but focused on mathematical equations
to avoid intentional attention to the participant . Sessions were consistently conducted I
hour following analgesic medication. Participants completed the Well-Being Scale on day
I for a baseline measure and before and after sessions on days 2, 3 , and 4. The Well-Being
Scale is a visual analogue scale evaluating several indicators of physical and emotional
comfort . Each of nine indicators (pain, nausea, depression, anxiety, shortness of breath,
activity, appetite, relaxation, and inner peace) is set up on a 1 0-cm line with anchor words
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to describe the end points of the scale, for example, "no pain" (0) to "severe pain" ( 1 0).
This scale demonstrated adequate internal consistency Using chi-square and i-tests, no
significant differences were found among the groups on any demographic or medical
variables. No significant baseline differences were found for sense of well-being and mean
dose of analgesics or anxiolytics. Using repeated measures analysis of variance, individuals
in the TT group experienced statistically significant increases in well-being compared to
those in the rest period control group. Attention to methodological rigor included random
group assignment, homogeneity evaluations of the two groups, consideration of analgesic
and anxiolytic medications as covariates, control of environmental conditions during the
sessions (noise, interruptions, and temperature), and adequate TT practitioner training and
experience. The major limitations were small sample size and the potential of unconscious
influence of the researcher/practitioner who both administered treatments and collected
data.
TT and immune function. The effects of TT on immune function have been
investigated in three studies. One doctoral candidate explored the effects of TT on coping
response and immune function in 20 HIV-seropositive males (Garrard, 1 995). Participants
were matched according to age, pharmacological therapy, and CD4+ lymphocyte counts,
then randomly assigned to either the experimental or sham (mimic) TT group . Coping
responses were measured using the Coping Resource Inventory (CRI S), which yields a
global score called the Coping Resource Effectiveness Score. The CRIS is comprised of
1 5 subscales. Internal consistency of the CRI S was assessed and found to be sufficient on
each of the subcales, with coefficient alpha scores ranging from . 84 to .97. Test-retest
reliability yielded a high level of stability (r= 95) TT as well as sham TT was administered
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by a single practitioner certified in TT. All sessions lasted 20 minutes; TT sessions
consisted of a 5-minute assessment followed by 1 5 minutes of treatment in which the
practitioner redirected the flow of energy. The sham treatment consisted of the
practitioner entering the participant ' s room, standing at the head of the bed, then leaving
the room 20 minutes later without having done any TT. Participants were blinded to group
assignment They wore sleep masks and headphones during sessions. C04+ lymphocyte
counts and coping effectiveness were assessed at baseline and at 3, 6, and 9 weeks. The
specific number of sessions was not specified. However, the author stated that 9-week
measures were done 3 weeks following the cessation of sessions. Using analysis of
variance, statistically significant increases were found at week 9 in C04+ cell counts and
overall coping effectiveness in the participants who received TT. Findings were not
statistically significant at weeks 3 or 6 Even with a small sample size, this study
demonstrates strength in the areas of matching participants for potential covariates,
treatment randomization, blinding, and the use of a reliable and valid coping instrument
However, post-intervention C04+ cell counts were displayed in a graph so that actual
values are not easily determined . In viewing the graph, elevations in C04+ cell counts
appear to be modest and are not increased consistently in all participants, making it
difficult to determine any potential clinical significance of this finding.
Two trials investigating the effects of TT using a PNI framework have been
published in peer-reviewed journals. Olson and colleagues ( 1 997) discovered a statistically
significant trend toward enhanced immune function following TT in healthy college
students experiencing the stress of upcoming graduate entrance exams. A sample of 20
healthy medical and nursing students were randomized to the TT treatment group or the
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no treatment control group. An experienced TT practitioner who was not responsible for
data collection did TT. Measures included three psychosocial instruments (Spielberger
State/Trait Anxiety Inventory [SST AI], the Impact of Events Scale [IES], and the Profile
of Mood States [POMS]), a demographic and health habits questionnaire, and
quantification of antibody response to the Haemophilus influenzae vaccine, serum
immunoglobulin levels (IgG [including subclasses], IgA, IgM), and lymphocyte subsets.
Using !-tests, differences between groups were significant for a decrease in serum IgA and
an increase in serum IgM, but no significant differences were noted in serum IgG or its
subclasses. Changes in lymphocyte subset assays were not significant, including CD25+
levels, which were measured as a correlate of interleukin-2 receptor expression. There
were no differences between groups in levels of antibodies to Haemophilus influenzae.
Further, statistically significant differences were not detected on any of the psychosocial
measures. The authors cited the small sample size and the presence of confounders such as
dietary changes during exams as possible explanations for the predominantly non
significant findings. Additionally, the possibility that TT does not affect immune function
must be considered.
Quinn and Strelkauskas ( 1 99 3 ) conducted the most comprehensive trial published
to date on the effects of energy work using a PNI framework. They investigated the
effects of TT on certain psychological and immunological parameters in bereaved
individuals. The investigators measured the effects of TT on practitioners as well as
participants to explore the premise that energy-based techniques affect both the
practitioner and the recipient . Despite some intriguing findings in Quinn and
Strelkauskas' s investigation, it was not designed rigorously and included only four
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participants and two practitioners Outcome measures included state anxiety, affect,
effectiveness of TT treatment, time perception, and four measures of immune function,
namely, lymphocyte subset composition; responsiveness toward foreign cells as shown by
mixed lymphocyte reactivity and cell-mediated cytotoxicity; lymphocyte stimulation using
phytohemagglutinin (PHA), concanavalin A, and pokeweed mitogen; and natural killer cell
assays. Participants experienced a 29% average decrease in state anxiety as measured by
the SST AI There was not a meaningful change in the anxiety scores of the practitioners,
perhaps because their anxiety scores were very low throughout the study. In participants
and practitioners, there were significant increases in all positive dimensions of the Affect
Balance Scale as well as significant decreases in all negative dimensions.
Using the Effectiveness of Therapeutic Touch Scale, the participants treated by
one practitioner scored 54% higher than did those treated by the second practitioner.
However, the practitioners differed in their levels of TT experience and amount of TT
practice time per week, and the more experienced practitioner received the higher scores.
Practitioners and participants were asked to estimate the amount of time that elapsed
during their session as a measure of the altered consciousness that is theorized to occur
with TT and HT. The participants treated by the more experienced practitioner perceived
greater lapses of time, implying greater alterations in consciousness, according to the
investigators. All participants and one practitioner experienced a decrease in the
percentage of suppressor T-lymphocytes (CD8+). The more experienced practitioner had
a low suppressor T-cell percentage at baseline and this finding persisted throughout the
study. Further evidence of enhanced immune function among participants included
improved lymphocyte responsiveness to foreign cells as well as heightened lymphocyte
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proliferation in response to mitogens and increased natural killer cell activity. Missing
data made it difficult to asses-s these immune measures in the practitioners. Because of
missing data and the small sample size, it is not possible to fully interpret the data in this
study. However, it provides a beginning for the exploration of the effects of energy work
in the context of the PNI paradigm.
This study exploring the effects of HT will build on and expand the strengths of
Quinn and Strelkauskas' s ( 1 993 ) investigation while avoiding the weaknesses of their
work. First, the experimental design proposed here allows for extensive scientific control.
Second, an adequate number of participants will be included. Third, HT practitioners will
all be nurses who have completed at least Level 3 A of HT training, signifying adequate
HT training, and will have comparable experience levels.
Summary of HT and TT research. In a review of the state of the research on the
effects of TT spanning 23 articles in 1 4 refereed journals, Easter ( 1 997) concluded, "the
findings of the research indicate positive regard for the use of Therapeutic Touch. All
research points to the need for further study in this area. Research methods used to date
are satisfactory, but it would behoove researchers to be more rigorous in research
methodologies to produce a truly scientific contribution to the body of nursing literature"
(p. 1 63 ) . The research reviewed here provides a representative view of the current state of
the science of HT and TT research. Consistent with Easter's review, the majority of the
research yields positive outcomes for these therapies. However, frequently the
researcher's conclusions are not congruent with the data presented. Additionally, Easter' s
call for increased scientific rigor, especially i n quantitative investigations, is corroborated
in this literature review. If research exploring the effects and experiences of HT and TT is
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to meaningfully contribute to the body of nursing literature, attention to appropriate
research design and methods' are necessary. The major limitations in the research reviewed
include inadequate sample sizes, lack of treatment randomization and control groups
(especially in the studies published in the HT International Research Survey), possible
practitioner-participant effects when the practitioner is also the researcher, mimic TT
sessions used as the control condition, potentially unreliable and invalid instruments,
underdeveloped theoretical frameworks, liberal interpretation of data, and failure to
consider the presented theory may be wrong when confronted with inconsistent data. The
clinical trial proposed herein involves consistency between the research questions and
methods as well as a sound theoretical framework and adequate scientifi c rigor. Thus, this
study should provide valuable information on the effects of HT in individuals with HIV
disease.
Well-being
Current conceptions of well-being are based in part on Larson's ( 1 978) meta
analytic review of trials spanning 30 years using a multiplicity of measures of affect . In
Americans over age 60, negative life situations such as poor health were correlated
negatively with well-being. Brook and colleagues ( 1 979) also found negative correlations
among subjective well-being, age, and general health ratings. Monk ( 1 98 1 ) found that
"labeling" individuals with the diagnosis of hypertension decreased psychological well
being and asserted this may be a phenomenon in any chronic illness.
While there is accumulating evidence that negative affect is associated with
immunosuppression (Kemeny & Dean, 1 995), there is relatively little research concerning
positive affect . It may be possible to impact positively physiological variables with positive

47

affective changes in individuals with HlY disease, given that some studies have shown
positive affective states to be associated with improved immune function and the opposite
for negative affective states. In one set of studies, T-lymphocyte proliferative response to
the mitogen PHA was enhanced by positive mood states and diminished by negative mood
state (Futterman, Kemeny, Shapin, & Fahey, 1 994; Kemeny et ai , 1 994). In an
exploratory study of the effects of stress and psychological status on humoral immune
response, Snyder and colleagues ( 1 990) found that psychological well-being was
positively correlated with postimmunization IgG levels and the opposite for psychological
distress. A total of 89 healthy female college students were immunized with keyhole limpet
hemocyanin (KLH). Life stress, psychological status, and serum IgG levels were measured
immediately prior to immunization and 3 and 8 weeks following immunization. Sample
size was calculated to be large enough to demonstrate a medium effect size. Participants
with greater psychological well-being had significantly higher IgG levels at all three
measurement times compared to those with lower psychological well-being.
Several issues arise when evaluating the outcomes of trials investigating positive
affective states such as enhanced well-being. First, empirical evidence to date remains
inconclusive and contradictory. For example, Futterman and colleagues ( 1 994) found that
positive as well as negative affective states enhanced NKC cytotoxicity. Second, none of
these studies has investigated well-being as this trial seeks to do. Correlates of well-being
such as coping effectiveness and hardiness have been investigated, but no global indicator
of general well-being has been included . Third, many studies have been fraught with
inadequate sample sizes and methodological flaws (McCain & Zeller, 1 996) that this trial
avoided. Finally, none of these trials have evaluated the effects of complementary
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therapies on the PNI parameters measured in this trial . In this study, relationships among
well-being, neuroendocrine mediation, and immune function were further investigated in
individuals with HIV disease.
Neuroendocrine Measures
Serotonin (5-HT). 5-HT is a neurotransmitter and hormone produced in the
central nervous system (eNS) that influences mood and well-being (Miller & Keane,
1 987). Neurotransmitters are signal molecules that mediate communication between the
endocrine, nervous, and immune systems. Research indicates that serotonergic
abnormalities are involved in the pathogenesis of anxiety and dysphoric states. Individuals
experiencing anxiety and/or dysphoria exhibit alterations in serotonergic functioning,
specifically, exaggerated re-uptake of 5-HT by eNS neurons. Selective serotonin re
uptake inhibitors (S SRIs) such as fluoxetine (Prozac) have been useful in treating anxiety
and dysphoria because they interfere with the re-uptake of 5-HT in the eNS . Research
into the dysphoric states associated with premenstrual syndrome (PMS) indicated
improvement in this negative affective state with similar medications due to the release of
central 5-HT and the prevention of its re-uptake (Brzezinski et aI . , 1 990) Generally,
increasing the amount of centrally circulating 5-HT lessens anxiety and elevates mood
(Baldwin & Rudge, 1 995).
Serotonin is also gaining acceptance as an immune modulator. Smith and
colleagues ( 1 99 1 ) reviewed the role of 5-HT in immune responses. In peripheral blood, 5HT is localized in platelets and released at sites of injury. Lymphocytes possess a high
affinity binding site for 5-HT. Mast cells can also take up and release 5-HT. With injury
or inflammation, mast cells release 5-HT which helps mediate local immune processes.
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Further, 5-HT augments NK cell cytotoxicity directly as well as indirectly through
monocyte stimulation and by -diminishing the suppressive activities of macrophages_
Basically, 5-HT is required for optimal T -lymphocyte activation as well as macrophage
accessory function for T-cell activation (Sosroseno, 1 995; Young & Matthews, 1 995)_ To
date, research on serotonin has focused on negative affective states such as depression and
PMS_ No research has been found investigating serotonin and positive affective states_
DHEA and cortisol. It is thought that severe illness causes an adaptive
adrenocortical shift manifested by increased cortisol and decreased DHEA concentrations
resulting in an increase in the cortisollDHEA ratio (Parker, Levin, & Lifrak, 1 98 5 ) _ In
HIV disease, cortisol remains elevated at all levels of infection_ There is a negative linear
correlation between CD4+ lymphocyte counts and cortisol whereas there is a positive
linear correlation with DHE A Additionally glucocorticoids, including cortisol, are
associated with alterations in cytokine production and the progression of HIV disease
perhaps because of a shift from a type 1 to a type 2 cytokine pattern as well as
programmed cell death (Clerici et aI . , 1 997)_
Recently it has been suggested that psychological stress, by virtue of increased
cortisol and decreased DHEA, may be associated with HIV disease progression (Clerici &
Schearer, 1 994; Jacobsen, Fusaro, Galmarini, & Lang, 1 99 1 ; Mulder et aI. , 1 992)_
Whereas cortisol stimulates HIV replication and augments humoral immune function,
DHEA has a reciprocal effect that includes inhibition of HIV replication and augmentation
of cellular immune function (Regel son , Loria, & Kalimi, 1 994)_ Reducing cortisol levels
may contribute to the attenuation or reversal of disease progression_
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While there have been no reports concerning positive affect and cortisollDHEA it
is postulated that enhanced welI-being may influence this ratio and thereby enhance
celIular immune function If negative affect increases cortisol and decreases O HEA,
thereby impairing immune function, then perhaps positive affect decreases cortisol and
increases OHEA, thereby enhancing immune function.
Immune Measures
Lymphocyte subsets. T -lymphocytes may mediate important host responses to
HIV infection including cytotoxicity and suppression of HI V as welI as pathogens
responsible for opportunistic infections (Carr, Emery, KelIeher, Law, & Cooper, 1 996) .
CelIular subsets designated C04+, C08+, C05 7+, and the mixed subset C08+/C057+
are useful enumerative measures because of their roles in immune dysfunction in HIV
disease. These four were chosen because the level of C04+ lymphocyte levels is a welI
established marker of HI V disease status and progression, and C08+, C057+ and the
mixed subset of C08+/C05 7+ lymphocytes contribute information about numbers of
cytotoxic immune celIs. C08+ lymphocytes are a subset associated with cytotoxic and
suppressor functions. C057+ lymphocytes are cytotoxic celI markers, thus the mixed
subset of C08+IC057+ contains both suppressor and cytotoxic cells. The C04+ and
C08+ lymphocytes are the most frequently studied of the subsets. For example, it is well
documented that C08+ celIs possess suppressor as welI as cytotoxic functions and are the
principle specific mediator of non-HIV virus eradication. Non-cytotoxic C08+ T -celIs
may play a vital role in preventing HIV disease progression. According to Levy and
colIeagues ( 1 996), the C08+ antiviral response occurs soon after infection and is
maintained in asymptomatic individuals. FinalIy, alterations in cytokine production are
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associated with CD4+ and CD8+ lymphocyte subsets (Rodriguez, Yano, Eylar, &
Yamamura, 1 997).
Lymphocyte proliferation. Clerici and Shearer ( 1 993 , 1 994) have extensively
studied the progressive dysfunction of the immune system in HIV disease. Viral
pathogenesis involves a progressive loss of T-helper cell function involving both CD4+
and CD8+ lymphocytes. The T -lymphocyte response to recall antigens such as tetanus
toxoid is the first function lost, followed by loss of T -helper cell response to allogeneic
major histocompatability complex, and finally, loss of T -helper cell reactivity to
phytohemagglutinin( PHA) Lucey and colleagues ( 1 99 1 ) studied over 600 HIV-infected
but asymptomatic individuals and found that peripheral blood mononuclear cells (PBMCs)
from 3 4% of the individuals responded to all three stimuli, 40% were selectively
unresponsive to recall antigens, 1 1 % responded to PHA only, and 1 5% were unresponsive
to any of the stimuli. Progressive defects in the response to these stimuli are positively
correlated with disease progression and a more rapid decline in CD4+ T-cell counts.
Improvement of T-helper cell function independent of CD4+ counts has been observed in
individuals on HIV pharmacotherapeutic protocols (Clerici etal . , 1 992). These positive
changes in T -helper cell function correlated with a lower incidence of opportunistic
infections, once again independent of CD4+ counts.
NK cell cytotoxicity. NK cells are large granular lymphocytes and are
spontaneously cytotoxic to tumor and virally infected cells. Abnormalities in NK cell
function in HIV disease include changes in cytotoxic function, cell subset distribution,
cytopathology, and cytokine regulation (Brenner et aI . , 1 989). Because HIV disease first
manifests in qualitative immune dysfunction (Clerici et aI . , 1 989), functional, rather than
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enumerative immune measures may be more accurate indicators of disease status over the
disease trajectory (Nott et ai:, 1 995). Additionally, functional indicators of immune status,
particularly NK cell cytotoxicity, may be more sensitive to psychosocial factors than are
enumerative immune measures ( Kiecolt-Glaser & Glaser, 1 992; Schulz & Schulz, 1 992).
However, it must be acknowledged that functional assays are performed in vitro in an
environment that is markedly different from in vivo measures in terms of endocrine and
other physiological influences, making it difficult to know how well these assays reflect in
vivo cellular functioning.
Cvtokines. According to C1erici and Shearer ( 1 993, 1 994), an immune system
imbalance occurs in HIV -infected individuals that generally weakens the immune system
and accelerates the progression to AIDS. They proposed that a shift from "type I " to
"type 2 " cytokine regulation was a critical step in the progression of HI V infection. Type
I regulation primarily involves the cellular immune system and type 2 the humoral immune

system. A type I pattern enhances cytotoxic function to protect the body against infection
by viruses and intracellular pathogens, whereas a type 2 pattern enhances antibody and
allergic responses. Ideally, optimal function of both types of responses is desired to
control HIV replication and disease progression. However, in some cases, cross
regulation of these two responses fosters stimulation of one at the expense of
inhibition of the other. Thus, as the type I response is progressively diminished in HIV
disease, the type 2 response is enhanced and the body loses its ability to fight opportunistic
infections (Mosmann, 1 994). Manipulation of the cytokine network is currently thought to
be a potentially important strategy in the control of HIV replication and thus disease
progression ( Poli & Fauci, 1 996)
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In this study, a type I cytokine pattern will be represented by IL-2 and TNF - a and
a type 2 cytokine pattern will be represented by IL-4 and IL-6. Although research does
not consistently support a type I to type 2 shift, Shearer and Clerici ( 1 993 , 1 994) have
presented some compelling findings. For example, IL-2 and other type I cytokines (lL- 1 2,
IFN-y ) have been shown to reduce apoptotic T-cell death as did antibodies against the
type 2 cytokines IL-4 and IL- I O . In contrast, I L-4 and IL- I 0 as well as antibodies against
the type I cytokine IL- 1 2 did not prevent, and in some cases increased, cell death. Also,
antigenic stimulation in a dominant type 2 environment resulted in an increase in the
proportion of dying cells, whereas these cells can be rescued if antigenic stimulation
occurs in a dominant type I environment . Finally, Clerici and Shearer ( 1 993 ) as well as
Chehimi ( 1 994) found that adding IL- 1 2 to cultures of PMBC ' s from HIV -infected
individuals restored cellular immune function, including NK cell activity, IFN-gamma
production, and lymphocyte proliferation to recall antigens.
Currently, the cause of the shift from type I to type 2 regulation as well as other
HIV -associated immune dysfunction is not known. While it is known that medication can
help reverse immune dysfunction in some individuals, it is not known if other therapies will
be useful. It was theoretically sound to suggest that therapies such as HT may support or
augment the immune system by enhancing well-being, thereby
increasing serum serotonin and DHEA and decreasing cortisol, and subsequently, helping
to maintain type I cytokine regulation, inducing a shift from type 2 to type I, and/or
enhancing cellular immune function by other mechanisms.
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Summary
According to Ader ( 1 992), a leading researcher and founder of the PNI field, "an
assessment of the clinical relevance of behavioral influences on immune function requires
strategies that follow from a conceptual model of integrated processes of adaptation and a
multi-determined concept of health and disease" (p. 6). Because of its grounding in PNI,
this study entailed that kind of research strategy. There are no reports of research
investigating the specific treatment and outcomes outlined here. HT and the outcomes
measured were grounded solidly in the PNI framework, and there was adequate related
theoretical and empirical evidence to support the investigation of the effects of HT on
well-being, serum 5-HT levels, DHEA and cortisol, and immune function.

Chapter 3
Research Design and Methods
The purpose of this study was to ascertain the effects of HT on selected PNI
parameters in HIV-infected participants. It was hypothesized that HT would increase
participant well-being, which would increase subsequently both serotonin and DHEA and
decrease cortisol, and ultimately enhance immune function. This purpose was addressed
using an experimental pretest-posttest design comparing the effects of HT on selected
psychoneuroimmunological parameters in individuals living with HIV disease. A wait-list
crossover control group was used to enable every participant to receive treatment.
Participants who agreed to participate voluntarily in the study were enrolled and
randomized to (a) the wait-list control group or (b) the immediate treatment group. Time
I measures were done immediately before the first treatment session or beginning of the

waiting period, and time 2 measures were done immediately following the last treatment
session or the end of the waiting period (and simultaneous start of the first treatment).
Immediately before the initial treatment session and immediately following the final
(fourth) treatment session, participants completed the General Well-Being schedule
(GWB), the Faces Scale, the Human Field Image Metaphor Scale (HFIMS), the brief
Profile of Mood States (POMS), and the Impact of Events scale ( IE S), and had blood
drawn for 5-HT and immune measures. Additionally, immediately before and after each
session, and 4 to 6 hours after receiving HT, the Faces Scale was completed by
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participants. Salivary samples for DHEA and cortisol were collected by participants upon
arising the day of data collection. There were five certified HT practitioners, each
performing 20-25 HT treatments, for a planned study total of 1 20 treatments ( 3 0
participants each receiving 4 treatments).
The target population was males living with HIV disease who met the enrollment
criteria. Because of the small sample size and the effects of gender on neuroendocrine and
immune measures, women were not included in this study. A sample of 30 individuals was
recruited to receive the HT intervention. Simple random sampling was used to assign
participants to the wait-list or immediate treatment groups. All participants had to have
been male, at least 1 8 years of age, able to read and speak English, and deemed to be
physically able to attend sessions (as demonstrated by Karnofsky performance scores of at
least 60, [Appendix C, Attachment 3 ] ). Participants could not have been taking steroids
or immunomodulatory drugs (including cytokines, thymic derivatives, and antineoplastic
agents, but excluding mV-related antiretroviral drugs). Additionally, participants must
have had a CD4+ lymphocyte count of at least 50 cells per microliter within 3 months of
study participation in order to have immune measures drawn. Potential participants were
screened and excluded for (a) significant psychiatric illness, including active psychoses,
dissociative disorders, severe or unstable depressive disorders, and organic mental
disorders or (b) cognitive impairment, evidenced by a score of less than 20 on the
Cognitive Capacity Screening Examination (Jacobs, B ernhard, Delgado, & Strain, 1 977
[Appendix C, Attachment 4]) . It was acknowledged that antiviral medications are
immunomodulatory. Therefore, participants were excluded if there had been antiretroviral
medication regimen changes (dose and/or drug) within one month prior to study
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enrollment. Additionally, controlling within subject variability was controlled by ensuring
that all participants who had antiretroviral medication changes (including dosages)
following enrollment were excluded from the immunological analyses. Beyond these
criteria, potential participants were not excluded on the basis of their disease status.
Human subjects: Recruitment, protection, and retention. Following approval of
the study by Committee on the Conduct of Human Research of Virginia Commonwealth
University, recruitment flyers were distributed in the Medical College of Virginia Hospitals
Infectious Disease and the Fan Free Clinics, as well as physicians' offices. Interested
individuals were screened and enrolled by the investigator. Participants were informed
fully about the study in accordance with all expectations for the protection of human
subjects. Those participants who volunteered to participate in the study were identified
only by an arbitrary identification (10) number. A file containing the participant's name,
informed consent document, and corresponding 10 number will be kept in a locked
cabinet in the investigator's office and will be accessible to the investigator and dissertation
chair only. Immediately following enrollment, participants were randomly assigned to the
wait-list control group or the immediate HT treatment group. To enhance retention,
participants were paid $50 upon completion of the study. Wait-list participants were paid
$25 at the end of the wait-list period and an additional $50 following their final HT
session. Additionally, participants were contacted by phone each week to remind them of
their appointments.
Demographic Variables and Potential Cofactors
During enrollment, pertinent demographic data were collected using a data record
form (Appendix C). Additionally, enrollment procedures included data collection on two

58

critical cofactors: Centers for Disease Control (CDC) classification (CDC, 1 992)
(Appendix C, Attachment 1 ) and the revised HIV Center Medical Staging Scale
(rHCM SS) score (McCain et aI . , 1 998) (Appendix C, Attachment 2). The CDC
classification system has widely recognized clinical and research utility. It is a nominal
level scale that rates categories of disease across three levels of clinical symptoms and
three levels of immunological status. Clinical symptoms are categorized as Stage A for
acute and asymptomatic infection, Stage B for non-life threatening and non-AIDS
opportunistic illnesses, or Stage C for AIDS-defining conditions including life-threatening
opportunistic illnesses. The three levels of immunological status are reflected by CD4+ T
lymphocyte levels 1 = 500 or greater, 2= 200-499, and 3 < 200 .
Despite its acceptance and frequent use as an indicator of HIV -disease
progression, the CDC scale provides limited information. For this reason, the rHCMSS
was also used as a measure of HI V-disease status and symptomatology (McCain et aI. ,
1 998). The rHCMSS provides a measure o f the progression o f H I V-related
symptomatology that is not confounded by psychiatric symptoms or immunological status.
The original HCMSS was developed by Gorman and colleagues ( 1 992) based on 1 986 and
1 987 CDC criteria which did not include HIV-related conditions specific to women.
Additionally, it was tested by physician providers only. The revised version is based on
1 992 CDC criteria, includes updated Category B and AIDS-indicator conditions, as well
as delineated anchor definitions for progressive scoring within each of the four major
staging categories. According to McCain and colleagues, the validity of the rHCMSS was
assessed as part of a larger study in a sample of 1 24 individuals living with HIV disease.
Pearson' s correlation between the rHCMSS and the CDC classification was . 80,
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demonstrating adequate construct validity. Validity was further supported by correlations
between rHCMSS scores and· C D4+ count (r= -.44) and CD4+ percentage
(r= -.62).
Because the sample size was limited to 30 participants, potential covariates were
chosen carefully to reduce the confounding of excessive, redundant, or insignifi c ant
cofactors. Although viral load is a potential covariate in HIV disease, viral loads were not
measured in this study because of financial limitations. Additionally, with current
pharmacological regimens for treating HIV infection, many individuals have undetectable
viral loads. Other potential cofactors include psychoactive drug use, excessive alcohol use,
age, amount and intensity of physical exercise, and malnutrition, as evidenced by weight
loss > I 0% of usual body weight . Baseline data were collected on all covariates to enhance
clarity and accuracy of the results. However, because of the limited sample size, it was
anticipated that the statistical model would allow inclusion of only the most critical
cofactors of rHCMSS score and CD4+ lymphocyte counts.
Independent Variable: HT
HT practitioners who participated in the study had completed at least level 3A of
HT training, signifying they had completed at least four of the five levels of HT training.
This criterion minimized variability among treatments by ensuring that practitioners had
similar training and extensive experience working with clients. Additionally, every attempt
was made to select practitioners with comparable amounts of experience and practice time
per week. HT practitioners were selected from the local pool of certified practitioners
based on their availability to provide treatments throughout the study. Participants' weekly
HT sessions lasted 20 to 30 minutes and included the chakra connection technique. HT
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sessions began with the practitioner setting her intention to help the recipient. Chakra
connection involves placing the hands on the participant's energy centers or chakras to
assess, then balancing each of the seven major chakras (ground, sacral, solar plexus, heart,
throat, brow, and crown). Chakra connection is a general technique that balances the
overall energy field The format of this technique is illustrated in Appendix B and was
followed as precisely as possible to ensure equivalence of the HT treatments. HT sessions
were conducted in a standard, private hospital room in the General Clinical Research
Center (GCRC) Basically, the rooms consisted of a table, chair, and adjustable hospital
bed.
To ensure understanding of and adherence to the HT protocol, the investigator
met with the HT practitioners involved in this study prior to the onset of the study to
review the protocol. The investigator then met with practitioners following the first HT
sessions and prior to the beginning of subsequent groups of participants (wait-list
participants' intervention) to review the protocol. HT practitioners were asked to follow
the chakra connection technique as it appears in the standard HT manual . Additionally,
they were asked to perform pre- and post-treatment assessments on each participant and
record their observations on a standard HT assessment form (Appendix B, Attachment 1 ).
These assessments were used to provide insight and clarification in data analysis and
interpretation. At the first treatment session, participants were assigned arbitrarily to
practitioners. Following this initial assignment, practitioners continued to work with the
same participants to the extent possible.
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Dependent Variables: Well-being, 5-HT, DHEA, Cortisol and Immune Measures
Psychosocial measures. Five psychosocial measures were used in this study
including four measures of well-being as well as an illness-specific psychosocial instrument
(included as Appendix D) to assess the immediate as well as cumulative effects of the
intervention. The most direct measures of well-being were the General Well-Being
schedule (GWB ) and the Faces Scale. The GWB consists of 1 8 questions, whereas the
Faces Scale is completed by circling a single face. The shorter format of the Faces Scale
allowed assessment of well-being immediately before and after each treatment session
while minimizing the workload of the participants. Additionally, single-item indicators
may yield more valid data when the variable of interest is
the participant's overall perception of an experience (Youngblut & Casper, 1 993). No
studies have been reported using either of these scales in the HIV population.
As a multi-item indicator the GWB is a comprehensive measure of well-being
which reflects both positive and negative feelings on the six dimensions of anxiety,
depression, general health, positive well-being, self-control, and vitality (McDowell &
Newell, 1 996). The first 1 4 items use 6-point response scales representing intensity or
frequency and ask questions such as, "Have you been under or felt you were under any
strain, stress, or pressure during the last month," with answers ranging from a score of " 1 "
for the strongest agreement (e.g. ,"Yes, almost more than I could bear or stand") to "6" for
the strongest disagreement (e.g., "Not at all"). The final four items ask for responses using
marks from 0 to 1 0 on a horizontal visual analogue scale to questions such as, "How
concerned or worried about your health have you been during the past month?" Responses
range from a low of "not concerned at all" to a high of "very concerned." Total scores
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range from 1 4- 1 24, with lower scores representing more distress and higher scores
representing positive well-being Responses also can be assessed according to the six
individual subscale scores with a range of two to four questions comprising each subscale.
Considering the complexity of issues relating to living with HIV disease, a scale that
encompasses multiple aspects of well-being was not only appropriate, but also necessary
in order to achieve a valid measure of well-being.
Monk ( 1 98 1 ) assessed the 3 -month test-retest reliability of the GWB in two
different groups from data collected on adults aged 25-74 years who participated in the
Health and Nutrition Examination Survey conducted from 1 97 1 - 1 974 and found
reliabilities 0[68 and . 8 5 . Fazio ( 1 977) reported a 3-month test-retest reliability 0[ 85 in
a sample of 1 95 college students. Internal consistency of the GWB is consistently high,
with Cronbach's alpha ranging from . 8 8 to 95 (Fazio; Himmelfarb & Murrell, 1 98 3 ) . In
the study conducted by Fazio, alpha coefficients were . 9 1 for 79 males and . 95 for 1 1 6
females Himmelfarb and Murrell ( 1 98 3 ) reported alpha coefficients of . 92 in 1 09 older
persons in inpatient psychiatric units and . 8 8 for 279 elders
living in the community Fazio reported discriminant validity scores of .47 when the GWB
was correlated with an interviewer' s rating of depression, .66 with Zung's Self-rating
Depression Scale, and . 78 with the Personal Feelings Inventory-Depression
The Faces Scale demonstrated an average test-retest reliability of . 70 in Andrew
and Crandall's 1 976 test of the validity of over 30 measures of self-reported well-being in
222 adults. In this sample, the median validity coefficient for the Faces Scale was . 8 2
when tested using a multimethod-multitrait investigation i n which six aspects o f well-being
were assessed by four methods using structural modeling to partition variance. Andrews
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and Crandall concluded that the validity score of the Faces Scale was among the top three
of the instruments tested. In

a

review of research using single-item indicators, Youngblut

and Casper ( 1 993) found that these measures generally yielded acceptable reliability
estimates and performed consistently well in validity testing. According to Hurny and
associates ( 1 996), " mood as a global concept can validly be assessed with a single-item
scale" (p. 245 ) . They asserted that single-item indicators are suitable for clinical trials
when multi-item scales are less feasible, which is the case with measures before and after
each treatment session. Although they emphasized that single-item scales capture only one
aspect of a concept, this was not a major concern with this study because a
multidimensional indicator was also being used .
The third measure of well-being was the 1 7-item short version of the Profile of
Mood States (POMS) (Cella et ai , 1 987) The POMS is a widely used, standardized
measure of mood comprised of 65 items which yield the Total Mood Disturbance Score
(TMDS) as well as six subscale scores. The short version is preferred because of its ability
to elicit a measure of TMDS, or positive/negative affect, efficiently and accurately. The
original I I -item brief POMS was derived by factor analysis of the full POMS from a
sample of 6 1 9 adults with various types of cancer, then replicated in a sample of 295
adults with lung cancer (Cella et ai , 1 987). In this population the brief POMS
demonstrated a Cronbach' s alpha of . 9 1 . Discriminant validity was supported in two
groups of patients with specific cancers, pancreatic and gastric. Based on earlier data, the
authors knew that scores in pancreatic cancer patients were significantly higher than those
of gastric cancer patients, presumably because of a tumor-mediated paraneoplastic
syndrome present in pancreatic cancer. When the data from these two subgroups were
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analyzed, the mean scores were higher in the pancreatic cancer group compared to the
gastric cancer group. Subsequently, six positive affect items (the original 1 1 items are all
negative affect items) were incorporated into the brief POM S to produce the current 1 7item scale.
The fourth measure related to well-being used in this study was the Human Field
Image Metaphor Scale (HFIMS) The HFIMS was chosen for two reasons. First, it was
developed based on the Science of Unitary Human Beings, a nursing theory applicable to
HT because of its focus on humans as energy fields. Secondly, it is consistent with the
conception of well-being as a reflection of perceived human potential (Dossey et aI. , 1 995;
Bradburn, 1 969). The HFIMS is a 5-point Likert-type scale consisting o f 2 5 metaphorical
items beginning with "I feel. " The potential range of scores on the HFIMS is 25 to 1 25 .
The higher the score, the clearer the field image. I t has been postulated that clear field
images are correlated positively with knowing participation in life choices and changes,
especially those related to health and well-being. A blurred field image corresponds to a
passive acceptance of life experiences.
The HFIMS is a reliable and valid measure of perceived potential and integrality.
Psychometric properties of the HFIMS were assessed in a pilot study of 50 and a major
study of 3 5 8 healthy adults. Final results yielded a 25-item scale with three factors that
were labeled "expressions of clear human field," "expressions of a blurred human field
image," and "integrality." In pilot testing the HFIMS demonstrated a Cronbach' s alpha of
. 93 and in major testing, .9 1 . Construct validity was assessed in both studies by correlating
the HFIMS with the Index of Field Energy, a related but not identical instrument .
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Using the Pearson product-moment correlation, a convergent validity score of . 59 was
found in pilot testing and . 70 in major testing.
An additional psychosocial measure used in this investigation was the Impact of
Events Scale (IES). The IES is a measure of illness-specific psychological distress. Mood
is conceptualized in this study on a continuum anchored by positive and negative affect, or
psychological well-being and distress. The IES was an appropriate measure in this clinical
trial, in part because the other measures of well-being, while they also capture negative
affect or distress, had not been previously tested in the HIV population. Using the IES,
psychological distress related to living with HIV disease has been previously documented
as avoidant and/or intrusive thought processes related to the illness (Ironson et aI. , 1 990;
McCain & Cella, 1 995; McCain, Zeller, Cella, Urbanski, & Novak, 1 996; Perry et aI . ,
1 992). The I E S i s a I S-item instrument comprised o f two subscales, intrusion and
avoidance, that yields an index of illness-related psychological distress. It was developed
by Horowitz, Wilner, and Alvarez ( 1 979) based on the premise that research on human
responses to stress requires evaluation of serious life events as well as their subjective
impact. The lES exhibits exceptional psychometric properties and is not confounded by
physical symptoms (McCain & Cella, 1 995; McCain et aI . , 1 996). In a sample of 66
persons with stress response syndromes, the split-half reliability of the total scale was . 86.
Internal consistency of the two subscales was high, as evidenced by a Cronbach' s alpha of
. 78 on the intrusion scale and . 82 on the avoidance scale. A correlation of . 42 between the
intrusion and avoidance scale signified they are associated, but do not measure the same
dimensions of distress. Test-retest reliability was assessed in a group of 25 physical
therapy students before and after dissection of a cadaver. Test -retest reliability of the total
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scale was r=. 87, . 8 9 for the intrusion subscale, and . 79 for the avoidance subscale. The
IES contains response options indicating the frequency of distressing (intrusive or
avoidant) thoughts over the prior 7 days. Higher scores on the subscales of intrusive and
avoidant thinking signify higher psychological distress.
Physiological measures. Pulse was measured by the HT practitioners before and
after each session as a gross indicator of physical relaxation. Biological measures included
salivary DHEA and cortisol, serum 5-HT levels as well as PBMC proliferative response to
PHA, NK cell cytotoxicity, lymphocyte subsets (CD4+, CD8+, CD57+, and
CD8+/CD57+), and selected type 1 (lL-2, TNF-a) and type 2 (lL-4, IL-6)
cytokine levels. Serum 5-HT levels were drawn and processed by the staff of the GCRC
Immediately following the study, frozen samples were shipped to LabCorp for testing.
Serotonin levels were assessed using high performance liquid chromatograpy (HPLC).
Salivary DHEA and cortisol were collected by participants upon arising the day of
data collection and processed by the GCRC Salivary DHE A has been validated as an
indicator of the unbound fraction of plasma DHEA Like salivary cortisol, unconj ugated
DHEA is liposoluble and rapidly diffuses from plasma to saliva, so that salivary
concentration is not dependent on salivary flow rate. Mean salivary DHEA has been
reported to be 392 pmollL in healthy individuals (Lac, Lac, & Robert, 1 993 ). Salivary
cortisol is a reliable indicator of the biologically active, unbound fraction of circulating
cortisol, with correlations between cortisol in saliva and blood typically greater than . 90.
Salivary cortisol concentrations accurately reflect changes in blood levels within two
minutes and are not influenced by salivary flow rates (Kirschbaum & Hellhammer, 1 992).
Expected biological variance in cortisol includes distinct circadian rhythmicity (with peak
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values at approximately 8 : 00 a.m. and nadir around midnight) and multiple ultradian
secretory bursts, in addition to environmental and situational reactivity (Baum &
Grunberg, 1 995; Kuhn, 1 989). However, unstimulated salivary cortisol measured at the
time of peak circadian levels and prior to appreciable environmental influences, that is,
immediately upon a.m. arising, have been shown to be consistent over sampling occasions
(Kirschbaum et aI . , 1 990), with normal values of 1 1 - 1 5nmollL (Kirschbaum &
Hellhammer, 1 992). Salivette (Sarstedt) sampling kits were used for saliva specimen
collections. Cryopreserved cortisol and DHEA saliva specimens were batch-processed.
DHEA levels were measured by radioimmunoassay ( Diagnostic Products Corporation)
and cortisol levels were measured by ELISA (Salimetrics) in the Core Laboratory of the
GCRC .
Lymphocyte subset assays were performed in the clinical Immune Monitoring
Laboratory under the direction of Dr. Pamela Kimball. To explore possible correlations
among helper/inducer and suppressor/cytotoxic T-lymphocytes with well-being among
persons with HIV disease, a number of lymphocyte subsets were examined in this study.
specifically CD4+, CD8+, CD57+, and CD8+/CD57+. These four were chosen because
CD4+ lymphocyte levels are a well established marker of HIV disease status and
progression, and CD8+, C05 7+ and the combined subset of C08+/C0 5 7+ lymphocytes
may contribute information about cytotoxic immune cell functions. Although considered
an incomplete marker, because they only mark a portion of cytotoxic cells, the C057+
subset is an enumerative measure of NK cells. Standard techniques for 2- color flow
cytometry were used (with Becton-Dickinson F AC Scan flow cytometer, F ACScan
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Research Software, and monoclonal antibodies) to identify the subsets of C03+, C04+,
C08+, and C057+ lymphocytes.
AU immune measures except lymphocyte subsets were done in the HIV
Immunology Laboratory (established through a grant to Dr. Nancy McCain from the
National Institute of Nursing Research), under the supervision of the Laboratory Director,
Dr. Kevin Brigle. All specimens were cryopreserved and performed in batch runs to
decrease inter-assay variability and control within-subject variability. Lymphocyte
proliferation was to be measured by stimulating lymphocytes to divide in vitro in response
to mitogens. Phytohemagglutinin (PHA) was the mitogen chosen because it is the most
potent mitogen of those commonly used and is consistent with the work of Clerici and
Shearer ( 1 993, 1 994). Mononuclear leukocytes were to be incubated first with control
medium or medium with PHA and subsequently with tritiated thymidine. The amount of
radioactivity incorporated by PHA-stimulated cells as compared to resting cells reflects
the level of lymphocyte proliferation (Fletcher, Klimas, Morgan, & Gjerset, 1 992).
However, lymphocyte proliferation assays were not done. The newly standardized assay
measuring lactic dehydrogenase release from lymphocytes did not perform reliably in our
laboratory standardization procedures. The laboratory was not licensed to use the
standard 3 -thymidine assay.
Using previously cryopreserved mononuclear leukocytes, NK cell cytotoxicity was
measured using a standard 4-hour chromium release assay with NK-sensitive K562 cells
(American Type Culture collection) as targets. NK activity levels were reported as % lysis,
calculated from the number of patient NK cells required to lyse 20% of the Cr-Iabeled
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target cells. Thus, higher NK cytotoxic function is indicated by higher lytic units
(Whiteside, Rinaldo, & Hebennan, 1 992)
In this study, standardized enzyme immunosorbent assay (ELI SA) kits
(Quantikine, R & D Systems) for cytokine quantification were used to examine peripheral
blood levels of selected cytokines. To test the hypothesis that enhanced well-being is
associated with a type 1 cytokine pattern, peripheral blood levels of IL-2 and TNF-alpha
were measured to reflect a type 1 cytokine pattern and IL-4 and IL-6 were measured to
represent a type 2 pattern.
Data Collection Procedures
Following enrollment and before the first treatment session, the participants turned
in saliva samples collected that morning, completed the GWB, IES, POMS, HFIMS, and
the Faces Scale and had serum 5-HT and immune measures drawn (Time I) . These
measures were repeated after 4 weeks, at the completion of four HT sessions (Time 2).
Additionally, the Faces Scale was completed immediately before and after each HT session
and again 4 to 6 hours following the session. The investigator, with the assistance of a
GCRC nurse, administered the psychosocial instruments to all participants. HT
practitioners did not perform any data collection except pre-and post-treatment pulse
measurements. Blood for measurement of the physiological variables was drawn by a
nurse in the GCRC using standard universal precautions and aseptic technique.
Data Entry and Analysis
Creation and formatting of the database was done by the investigator. The
psychometric data were scored by the investigator. All data were double-entered to verify
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accuracy. Data were entered into a spreadsheet format with pretest, posttest, and control
dependent variable data on the horizontal axis and participant ID code on the vertical axis.
Data were analyzed by the investigator using the SPSS 7 . 5 program. This
statistical program allowed for data management, analysis, and presentation. Reliability of
the well-being instruments was assessed using Cronbach' s alpha as well as test-retest
reliabilities using the wait-list control group data set . Construct validity was assessed
among the measures of well-being. Baseline equivalence of the treatment and control
groups was evaluated using stem and leaf plots to examine group differences on location,
spread, and shape (Verran & Ferketich, 1 987). The stated research questions of the study
were tested in the form of null hypotheses using multivariate analysis of covariance
(MANCOVA) MANCOVA allowed testing the difference among the means of two or
more groups for two or more dependent variables simultaneously, while controlling for
one or more covariates (Polit, 1 996) Following multivariate analyses, univariate analysis
of variance ( UNIANOV A) was performed to assess the contribution of individual
variables to the multivariate models. Additionally, correlational analyses were done to
assess the relationships among the variables. The significance level for all statistical
analyses was set at alpha

=

05.
Conclusion

HT is a potentially beneficial therapy for individuals living with HIV disease.
Research suggests it may indirectly enhance well-being. According to the PNI framework,
psychological states influence physiological functioning. PNI is the study of the
interactions between the brain and neuroendocrine and immune systems. Because it is
difficult to measure directly the potential energetic effects of HT, indirect measures of
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integrated psychological and physiological functioning are used currently to assess its
efficacy. For these reasons, PNI was used as the framework for this clinical trial
investigating the effects of HT in HIV -seropositive males. The majority of research to date
on energy-based therapies is flawed methodologically making it difficult to advocate
incorporation of these therapies into mainstream nursing care. This clinical trial was
designed to provide adequate scientific rigor for investigating the effects of HT on well
being and neuroendocrine and immune measures in individuals living with HIV disease.
This study contributes to the growing body of research in PNI as well as energy-based
therapies. These results do not support the use of HT as it was administered in this study.
Further research is needed before decisions can be make regarding the use of HT in HIV
care.

Chapter 4
Findings
The purpose of this randomized clinical trial was to evaluate the effects of the
energy therapy HT on well-being and neuroendocrine and immune function in individuals
living with HIV disease. A total of 30 males were enrolled in the study between February
and April, 1 999. A total of 27 individuals completed the study; one participant was lost to
follow-up and two participants withdrew following enrollment, but prior to starting the
intervention. Recruitment continued for five months, but efforts to replace these
individuals were unsuccessful. Of the 27 participants completing the study, 22 received
four 30-minute HT sessions and 5 received three 30-minute HT sessions. These five
individuals missed one treatment session and timely attempts at rescheduling were
unsuccessful. The pre-established protocol allowed participants to miss one session and
remain in the study.
Demographic Data
The demographic data indicated the study sample was similar to the local HIV
population, except no women were included in this clinical trial. There were no
statistically significant differences in the treatment and wait-list control groups on any of
the study variables at baseline. The mean age was 4 1 years (range 2 1 to 5 3 , SD= 7 5 3 );
52% of the participants were African American (n= 1 4) and 48% were Caucasian (n= 1 3 )·
The mean number of years of education was 1 4 (range 6 to 2 1 , SD= 3 92). A total of 59%
72
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of participants (!}= 1 6) were single, 1 9% (!}=5) were married, and 22% (!}=6) were
divorced or separated. According to the CDC classification system, 3 3 % (!}=9) of the
participants were Category A, indicating they were asymptomatic; 4 1 % (!}= 1 1 ) were
Category B, indicating they had experienced non-life threatening and/or non-AIDS
opportunistic illnesses; and 26% (!}=7) were Category C, meaning they had experienced
AIDS-defining conditions. The mean CD4+ lymphocyte count was 3 90 cells per microliter
or 24. 2% of T-lymphocytes, with a range from 5 . 6% to 47.3% (SD= 1 1 . 62). The average
rHCMSS symptomatology score was 1 9 (range 0 to 3 5, SD= 1 3 . 5 ) . Of the 27
participants, 23 were taking protease inhibitors. Of the remaining four participants, two
had never been placed on antiviral medications, one was taking ddI and d4T, and one was
taking only AZT because of multiple medication intolerances including protease inhibitors.
Two participants had only salivary measures because pre-baseline CD4+ lymphocyte
counts were less than 50 cells per microliter, which prohibited collecting serum samples.
Missing Data
Following completion of the study, approximately 4% of the data were missing,
virtually all because of participant non-response. The investigator also erred in not
collecting pulse measures on seven participants and occasionally missed administering
immediate pre- or post-treatment Faces Scales. With the exception of the pulse
measurements, the pattern for missing data was random. The majority of the participant
non-response missing data were the Faces Scales that should have been completed by
participants at home 4 to 6 hours following treatment. These Faces Scales were given to
participants in a packet to be completed following each weekly HT session. They were to
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be mailed to the investigator following the final HT session. However, only 1 6 of 27
participants returned these instruments.
The decision was made to replace data because in MANCOV A cases are deleted
listwise, meaning that if a participant is missing any variable included in the model, all of
the participant's data are deleted from the analysis. Missing data were replaced when no
more than 3 0% of the data were missing on any particular variable for a given participant .
Using the most conservative approach, missing data were replaced with a participant's
appropriate matched score. For example, if a pretest score was missing, the individual's
posttest score was substituted so that no change was introduced. Therefore,
conservatively replacing the data enabled a larger sample size for analysis, but a given
participant's outcome was not affected Although this approach potentially introduces a
substantial conservative bias, the group's mean score was not used because of the
relatively high variance in the data.
Instrument Evaluation
Reliability of four of the five well-being instruments was evaluated using
Cronbach's alpha as well as test-retest correlations using control group data. Because the
Faces Scale is a single-item measure, it was assessed using only test-retest reliability. The
desired instrument reliability score

=

. 70. As shown in Table 1 , with the exception of the

IES, which demonstrated low test-retest reliability, all of the instruments were internally
consistent and stable measures of well-being in this sample.
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Table I
.
We 11 - b emg nstruments : Re rlab ITltv 0ata

General Well-being
Sched ule (GW8)

Cronbach's alpha

Test-retest correlation

. 90

. 70

Faces Scale

.71

Profile of Moo d States
(POMS)

. 69

. 70

H uman Fiel d Image
Metaphor Scale ( HFIMS )

. 92

. 90

Impact of Events Scale
( IES)

.85

. 54

The correlation matrix illustrating the Pearson correlations for the five measures at
baseline is presented as Table 2 . Construct validity was demonstrated through discriminant
and convergent validity. The instruments refl e cting positive well-being (GWB, Faces
Scale, and HFIMS) were negatively correlated with those instruments refl e cting
psychological distress (POMS and IES). Additionally, the instruments were positively
correlated with each other within the aforementioned groupings.
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Table 2
Instrument Correlations (Sil!nificance Level) at Baseline
GWB

FACES

( !!= 2 7 )

( !! =22 )

POMS C!!= 2 7 )

HFIMS

I ES

( !!= 2 7 )

( !!= 2 7 )

GWB

1 . 00

FAC ES

. 50 (Q= . 0 1 7 )

1 . 00

POMS

- . 7 2 (Q<.OO I )

-.67 (Q= .OO I )

1 . 00

H Fi M S

.26

A 5 (Q= . 0 3 8 )

- . 3 8 (Q= .O.t8)

1 . 00

-. 1 5

-. 3 2

.35

-.28

1 . 00

IES

Hypothesis Testing
Specific research hypotheses were that HT would ( 1 ) enhance well-being, (2)
increase levels of serum serotonin and salivary DHEA, ( 3 ) decrease levels of salivary
cortisol, and (4) enhance immune function in persons with HIY disease. The effects of HT
were first assessed using multivariate analysis of covariance (MANCOY A). Because of
the small sample size, three separate multivariate models were created. The first model
was comprised of the psychosocial measures (GWB, Faces Scale, POMS, HFIMS, and
IES). The second model contained the physiological variables (pulse; serotonin; DHEA;
cortisol; CD4+, CD8+, CD5 7+, and CD8+/CD57+ lymphocyte subsets; and NK
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cytotoxicity). The third model contained the cytokines (IL-2, TNF-alpha, IL-4, and IL-6).
In addition to the small sample size, the cytokines were placed in a separate model because
they were the most tentative measures of immune function. To explore further the
relationships among the variables in this study and to guide further univariate analyses to
investigate the significant multivariate physiological findings, correlational analyses were
done (Table 9). Because of the small sample size of the physiological variables, non
parametric Spearman's correlations were used. Following analysis of the multivariate
models, exploratory analyses were done using univariate analysis
of covariance (UNIANOY A) Baseline CD4+ levels and rHCMSS scores were the
covariates used in all of the multivariate and univariate statistical analyses. Finally, to
further evaluate the findings in this study, pre- and post-intervention means and standard
deviations were examined to explore trends in the data.
Multivariate Psychosocial Model
Hypothesis 1 . It was hypothesized that HT would enhance participant well-being.
According to the multivariate statistical test, there were no measurable differences in well
being in the treatment group following HT as compared to the wait-list control group
(Table 3 ) . There was a significant time effect, which indicated both groups changed over
time. There was not a significant interaction effect for group by time. Because of the
significant time effect in the multivariate model, each variable was assessed using
univariate analysis of variance (UNIANOYA) to identify the differences that contributed
to this finding. However, there were no statistically significant findings in the univariate
analyses.
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Table 3
M ufIvanat e An alvsls
I
0 f C ovanance: P svc hosoclal Model
.

Effect

.

Wilk's Lamb d a
(dO

I!

Group

.60
(6, 1 2)

. 03

Time

. 42
(6, 1 4 )

.3 1

Group by Time

.65
(6, 1 4)

. 33

There were three univariate tests conducted on the Faces Scale data. The Faces
Scale was completed by participants ( 1 ) before beginning and following completion of the
4-week HT intervention. Additionally, this scale was completed (2) immediately before
and after each HT session as well as ( 3 ) 4 to 6 hours following each HT session. The postintervention Faces Scale was the only well-being measure to approach a statistically
significant change, with a trend toward higher scores at time 2 for both the treatment and
control groups (12= . 06). Pre- and post-intervention mean scores and comparative analyses
for all psychosocial variables are presented in Table 4. Finally, although no significant
change in well-being was detected following HT, there were trends in the mean scores of
each of the instruments in the expected directions post-intervention; scores on the GWB,
Faces Scale, and HFIMS increased and scores on the POMS and IES declined.
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Table 4
.
.
P SVC hOSOClaI V anabl es: M ean s cores an d UN IANOVA
G roup

Mean

SD

F

I!

@)
GWB

Treatment

Pre 6·U9

1 3 .6 1

1 .27

Post 6 9 . 80

5 . 74

Wait-List

(I)

Pre 7 ·U 8

6.34

Control

Post 6 9 . 7 5

7.40

( Range 1 41 24)

Total Sample
Faces Scale

Treatment

( Range 1 -7)

Pre 6 9 . 4 1

1 1 . 62

Post 6 9 . 46

6.47

I m med Pre

.93

. 2 50

5.19

.95

(I)

.275

.623

Immed Post
5 . 80

1.38

.016

. 902

(I)
4-6 H r. Post
(w/lmmed

1 .38

4 08

Post) 5 . 5 9

U6

(I)

Wait-List

Pre 5 4 2

1 75

Control

Post 6 . 00

115

Total Sample

Pre 4 6 9

.062

1 . 59
1 . 24

Post 6 . 00
Pre 5 04
Post 6 . 00
H FIMS

Treatment

Pre 6 5 . 7 9

2 11 2

. 529

Post 70.89

2 3 . 74

(I)

Wait-List

Pre 5 5 .69

2 1 . 10

Control

Post 60.69

23.4 1

Pre 60.93

21.12

Post 65 . 98

2 3 . 74

(Range 251 25)

Total Sample
POMS

Pre 1 2 . 7 1

10. 1 5

.238

Post 1 0 . 4 3

7 . 98

(I)

Wait-List

Pre 1 3 . 3 1

1 0 .64

Control

Post 9 . 85

8.45

Pre 1 3 .00

10. 1 5

Total Sample

Post 1 0 . 1 5

7 . 98

Treatment

Pre 1 5 . 2 1

1 3 . 26

1 20

Post 1 1 . 64

9.25

(I)

Wait-List

Pre 2 17 0

1 6 . 50

Control

Post 1 8 . 46

1 9. 4 7

Pre 1 8 . 3 3

1 4 . 98

Post 1 4 . 9 2

1 5. 16

Treatment

( Range 0-68)

IES
( Range 0-75)

Total Sample

.477

.632

.733

80

Multivariate Physiological Model
Hypotheses 2, 3, 4 . Because hypothesis 4 was related t o overall immune function,
it was included here as well as the following cytokine multivariate model. It was
hypothesized that HT would increase levels of serum serotonin and salivary DHEA,
decrease salivary cortisol, and enhance immune function in individuals living with HIV
disease. In the multivariate physiological model there was a significant treatment effect
(Table 5 ) . Additionally, like the psychosocial model, there was a significant time effect,
mearung both groups changed over time. However, there was not a significant group by
time interaction effect, which indicated the presence of a treatment effect independent of a
time effect. It must be noted that although there was a significant treatment effect, the
small sample size rendered the analyses unstable.
Table 5
Multivariate Analysis of Covariance. Physiological Model
Effect

Wilk's Lam b d a
(dO

Group

. 00
(9,2)

.001

Time

. 03
(6,7)

.01

Group By Time

.33
(9,4 )

I!

.

59

Because of this significant multivariate effect, each variable was evaluated using
UNIANOV A to detect which variables contributed to the overall multivariate effect None
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of the physiological variables demonstrated significant univariate results when tested
individually (Table 6).
Trends in the mean scores and standard deviations of the variables were examined
(Table 6). There was a modest decrease in the serum serotonin levels post-intervention in
the treatment group. There was a slight post-intervention downward trend in CD8+
lymphocytes levels in both the treatment and control groups. Although not statistically
significant, there was evidence of positive trends in the enumerative and functional
indicators of NK cells. Specifically, upward trends were observed in NK cell cytotoxicity
and there was no evidence of downward trends in CD57+ or CD8+/CD57+ levels in the
treatment group The absence of comparative data on the cytokines prohibits examination
of trends in the data.
The final physiological variable in the multivariate model was pulse rate, which
was assessed in 2 1 of the participants (the first treatment group did not have pulse
measures because the investigator neglected to instruct the practitioners to do so).
Although not statistically significant, there was a downward trend in mean pulse rates
post-intervention. However, it must be noted the decreases could have been associated
with rest alone because participants were lying down during their 20-30 minute session.
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Table 6
Physiological Variables: Mean Scores and UNIANOVA
Measure-

Group

Mean

S.rotonin (ng/ml)

Treatment

80 00
73 6�
Pre 91 33
Post 96 67
Pre 8 5 .j.j
Post 8-1 68
Pre

Post

Wait-list Control
Total Sample

OHEA (ng/ml)

Treatment

Pre I

58
I 59
Pre I 56
Post 1 67
Pre I 57
Post I 63
Post

Wait-list Control
Total Sample

Cortisol (pgIdl)

Treatment
Wait-list Control

Post

25
�-I

Pre

46

Total Sample

C057+ (%)

Treatment

Total Sample

C08+/C057+ (%)

Treatment

1 4 35
1 3 40
1 7 �I
1 3 28
1 5 59
1 3 06

330
(I)

573

2-1 9 5
�4 7 1
Pre 2.1 I I
Post �9 5 7
Pre 23 99
Post 27 2-1

1 2 27
1 0 37
8 85
8 96
1 0 41
9 78

22 -t6
11 93
Pre 1 8 90
Post 23 98
Pre 20 60
Post 2� 68

II

5 31
6 37
Pre 8 24
Post 6 73
Pre 6 6-l
Post 6 56

3 18
5 19
10 19
5 10
7 21
5 04

Pre

Pre

Post
Wait-list Control
Total Sample

N h: Cytotoxicity

Treatment

(1)1i< units)

Total Sample

Pulse (beals/min)

Pre

Post
Wait-list Control

Treatment

400

56 00
52 66
Pre 5-1 38
Post 5 1 n
Pre 5 5 44
Post 52 1 7
Pre

Post
Wait-list Control

67

804

Post

\\l.it·list Control

074

(I)

063
(I)

Pre

Treatment

3 65

.5 I I

1 3 28
1 3 -18
1 0 48
1 0 03
1 1 62
1 1 66

Trtatment

Post

C08+ (%)

70
-19
91
83
79

-152
(I)

2-1 4 0
�I 10
Pre 2-1 02
Post 1 8 03
Pre 2-1 20
Post 1 9 -19

58
38
Post -II
Pre

Total Sample

10
79
77
00
1-1
33

I!

748

Total Sample

Wait-list Control

66
65
76
97
70
81

r

®

-II
-II
50
-15
-II
38

Pre

Post

C04+ ( % )

SO

Pre
Post

8 7 00
80 0 1

33
10 1 7
8 10
9 36
9 72
9 58

8 31
9 71

(I)

I 22
(I)

.284

09-1
(I)

763

1 -18

706

(I)

407
(I)

532
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Multivariate Cytokine Model
Hypothesis 4 . I t was hypothesized that enhanced immune function would be
demonstrated by a predominant type 1 instead of type 2 cytokine pattern in the treatment
group following HT However, there were no statistically significant findings in the
cytokine multivariate model (Table 7)
Table 7
M u 1tlvanate
°
I
0 f C ovanance: Cyto kOInes
An alVSlS
°

Effect

Wilk's Lamb d a
( dO

Group

.71
(4,7)

60

Time

61
(4,9)

.29

Group By Time

70
(4,9)

.47

.

.

J!

For continuity within the data analysis procedures and to provide directions for
future research, univariate analyses were done on each of the four cytokines; none of these
results were significant (Table 8). Because of problems with dilution techniques in the
cytokine assays, data on group means and standard deviation scores are not reported.
Intra-individual comparisons are valid, however.
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Table 8
Cvtokines: UNlANOV A
Cytokines

.E
(dO

I!

I L- 2 (Type 1 )

. 92
(I)

TNF-(X (Type 1 )

. 19
(I)

.67

I L-4 (Typ e 2 )

. 26
(I)

.62

IL-6 (Type 2 )

. 53 0
(I )

.53

.

35
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Exploratory correlational analyses were done to assess further the relationships
among the study variables (Table 9; significant correlations are noted with asterisks).
There were no significant correlations between the scores on the well-being instruments
and the physiological measures. However, a number of significant correlations were found
among the physiological measures. There were no significant correlations found for
serotonin, DHEA, cortisol, or IL-4. Among the significant correlations, some were logical
and explicable, whereas others were not . As expected the subset of CD4+ helper
lymphocytes was correlated negatively with CD8+ suppressor lymphocytes and the mixed
subset CD8+/CD57+ . Similarly, CD8+, CD57+, and CD8+/CD57+ were correlated
positively. NK cytotoxicity was correlated positively with CD4+ lymphocytes and
inversely with the CD57+ and CD8+/CD5 7+subsets. The type I cytokines IL-2 and TNF 
ex were correlated positively. Both I L-2 and TNF-ex were correlated postively with IL-6,
perhaps indicating a type 0 cytokine pattern. The correlations among the various
lymphocyte subsets and cytokines may be explained by the fact that each cell subset
produces multiple cytokines.
Further exploratory univariate analyses were done by controlling baseline values
of a variety of the physiological variables as covariates. These models were constructed
based on the Spearman's correlational analyses as well as prior research. The only
significant model (12= .03) was for a decrease in post-intervention salivary cortisol while
controlling for baseline cortisol, DHEA, CD4+ lymphocyte percentage, and the rHCMSS
symptomatology score.
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Table 9
Correlational Analyses: All Psychosocial and Physiological Variables
COH

C OS 7 !

C08+

<:08+1

Cort

O I l �:A

1I�2

IIA

NKcyto

Sero

TNF

1L-6

CIlS7+
CIlH

1 00

CIlS7+

- 33

1 00

C1l8+

· 55 · ·

55"

1 00

C08+1

- 32

94··

67 "

1 00

C057+
Cort

�2

02

1.1

057

1 00

IlHEA

02

10

12

047

- 04

1 00

1 I �2

28

- 47 -

- 40

- 52-

- 00

- 04

1 00

1L-4

- 19

- 27

06

2�

- 21

27

10

1 00

:-IJo.:c�1o

53-

- 49 -

- 43

- 50

25

10

59 - -

13

1 00

Stro

01

- 27

04

- 30

- 15

18

28

38

40

1 00

TNF

32

- 15

- -' 5 -

- 31

- 37

18

56-

- 12

39

26

1 00

1 I �6

37

- -Ill

- 66··

- 5 9· ·

- 05

- U2

66--

- 26

36

07

59"

FaCe!

- 17

01

01

- 03

- 06

08

34

- 10

15

- 02

- 15

14

GWB

16

- 10

17

03

4 0-

- 05

19

20

21

04

- 08

08

I l FI M S

- 09

04

- 02

05

- 30

08

13

- 07

- 13

- 03

20

- 07

POMS

03

01

12

12

07

- 01

- 17

32

-

I

- 14

- 03

16

- 16

02

07

- 01

- 01

04

- 27

05

- 15

10

17

09

I ES

I

1 00

Summary
Using a multivariate analysis approach with univariate models constructed for
specific explorations, it was found that HT did not enhance well-being and neuroendocrine
and immune function as measured in this sample of individuals living with HIV disease.
There was a statistically significant treatment effect detected in the multivariate
physiological model, but there were no significant univariate findings to explain these
results. Additionally, the small sample size rendered the results unstable. There was a
significant decrease in cortisol when controlling for baseline levels of cortisol, CD4+
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lymphocyte percentage, and rHCMSS symptomatology scores. Discussion and
conclusions related to the findings follow.

Chapter 5
Discussion and Conclusions
The PNI paradigm provided a holistic framework for examining interactions
among well-being and the neuroendocrine and immune systems. This framework is
particularly applicable in immunologically mediated diseases such as HIV disease. Using
an experimental design and numerous controls, this clinical trial included the first global
indicators of well-being in PNIIHIV research. Study hypotheses related to the effect of HT
on well-being, neuroendocrine, and immune function in individuals living with HIV disease
were rejected. While the overall multivariate physiological model was significant,
differences in the individual variables were not significant. The findings did not support
treatment-related changes with the exception of decreased cortisol when critical covariates
were controlled. Although there were no other significant changes in the physiological
variables, the multivariate physiological model was statistically significant, most likely
because of additive effects of variables increasing or decreasing in the expected directions.
There was a significant time effect in both the psychosocial and physiological models.
According to the multivariate analyses, both the treatment and control groups
changed over time. This may have occurred because of the Hawthorne effect, or simply
because participants were happy to be participating in the study. This time-related change
in well-being and physiological status may have existed even with the control group
because of a placebo response related to participants being hopeful that HT would help
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them. Additionally, participants may have been happy they were receiving money for
participating in the study. It IS also conceivable that participants were affected by the
caring presence of the investigator, HT practitioners, and GCRC staff. It is a common
observation in nursing research that there is a therapeutic effect related to the nurse's use
of self in nursing interactions. The investigator was aware of this potential
effect and acknowledged the ultimate importance of therapeutic, humanistic interactions
while attempting to maintain a professional, objective relationship with participants.
Explanations for the absence of a treatment effect are numerous and include the
following: ( 1 ) the treatment did not work, (2) the treatment "dose" was insufficient to
produce measurable changes in the chosen PNI-based parameters, ( 3 ) a " standardized " HT
intervention may not be effective, (4) there was a ceiling effect related to the baseline level
of participant well-being and immune function, ( 5 ) small sample size, and (6) the PNI
based measures chosen may not have been sensitive enough to detect small effect sizes. It
is must be acknowledged that HT as it was delivered in this study did not appear to affect
well-being and immune function in these individuals living with HIV disease.
Based on prior research, HT sessions were designed to maximize treatment effects.
It is unlikely that the absence of a treatment effect was related to the HT practitioners
because all of the practitioners had adequate, similar levels of training and practice
experience. Although practitioners were given a 20-30 minute range for treatments,
virtually all of the participants received 3 0-minute HT sessions. In clinical practice
situations, HT sessions typically last 1 hour. Perhaps the duration of the session was not
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long enough. Additionally, it is conceivable that changes related to HT are appreciated
over time and were not detectable in the short 4-week course of this study. Qualitative
explorations provide contextually grounded information for theoretical consideration when
interpreting quantitative data in similar samples as well as directions for future research.
Samarel ( 1 992), following interviews with 20 individuals who had received TT, reported
that TT was experienced as a multidimensional process that fostered personal growth and
well-being over an extended time. Although this study involved substantially longer and
more frequent HT sessions than prior studies, it is conceivable that significant changes are
more effectively appreciated over longer periods of time.
There may have been a ceiling effect related to the participants' baseline well-being
levels and immune function The baseline scores on the psychosocial instruments were
relatively high for the measures of well-being (GWB, Faces Scale, HFIMS) and relatively
low for the two measures of psychological distress (POMS, IES). The participants in this
study were relatively young and healthy. The mean age was 4 1 years, the average
rHCMSS symptomatology score was 1 9 with a range of 0 to 3 5 , and the average C D4+
lymphocyte count was 3 90 cells per microliter. Further, the majority of the participants
(23 of 27) were taking protease inhibitors (PI). Of the remaining four participants, two
had never needed antiretroviral medications, one had never required PI, and one needed a
combination of antiretrovirals but was unable to tolerate medications other than AZT. In
responsive patients, current d rug therapy including PI reduces viral load often to
undetectable levels and increases CD4+ lymphocyte counts thereby decreasing morbidity
and mortality, which potentially enhances well-being.
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Because o f the impact o n the power of an intervention t o demonstrate statistically
significant changes, the small· sample size and missing data likely contributed to the
findings. Larger sample sizes are needed to achieve adequate power and stabilize variance
in the statistical tests. Finally, the PNI-based measures chosen in this study may not have
been robust enough to detect small effect sizes.
Well-being
With the exception of the test-retest reliability of the IES, the five psychosocial
instruments used in this study were found to be reliable and valid indicators of aspects of
well-being and psychological distress. Although there was no significant change in well
being post-intervention, there were trends in the expected directions in the post
intervention mean scores on each of the well-being instruments, in that scores on the
GWB, Faces Scale, HFIMS increased and scores on the POMS and IES declined. The
increase in the post-intervention Faces Scale scores approached a significant level (12=.06).
The Faces Scale may have been the most sensitive measure because it is the simplest, most
direct subjective measure of well-being. Hurny and colleagues ( 1 996) advocated the use of
single-item measures when assessing subjective states such as well-being and found that
they often performed better than multi-item well-being instruments. The IES is an event
specific measure and the only one that had been used previously in the HIV population,
but it was not a stable measure in this sample. However, because it measures
psychological distress in the past 7 days, there is no reason to expect that distress levels
remain stable from week-to-week.
Findings related to depressed mood and immune function in persons with HIV
disease have included decreased lymphocyte proliferation to mitogens (Futterman et aI . ,
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1 994; Kemeny et aI. , 1 994), decreased NK cell activity (Futterman et aI . , 1 994), and
alterations in WBC subpopulations (Taylor, 1 995) in depressed individuals. According to
the literature, negative life situations such as poor health are correlated negatively with
well-being (Larson, 1 978; Brook et aI. , 1 979). Additionally, individuals "labeled" with a
chronic illness can exhibit decreased well-being (Monk, 1 98 1 ). Clearly the theoretical
bases of the proposed hypotheses were sound. However, the study participants
demonstrated relatively high baseline levels of well-being and receiving HT, as it was
delivered in this study, did not enhance levels of well-being.
Neuroendocrine Measures
Serotonin. HT did not elicit significant changes in serum serotonin levels; the
possible mechanisms are unclear, but include the absence of a treatment effect (which is
consistent with the absence of significant changes in the other physiological variables),
incorrect theoretical propositions about the function of serotonin within the PNI
framework, and inappropriate measurement protocols.
A great deal remains unknown about the use of serum serotonin as a marker of
neuroendocrine status in general and in individuals living with HIV disease in particular.
Based on prior research, it was hypothesized that an enhancement in well-being would be
associated with an increased amount of circulating serotonin and, subsequently, this
increase in serotonin should augment immune function. However, there was no
statistically significant increase in pre- to post-treatment serum serotonin levels in this
sample. In fact, there was a trend toward a decrease in the serum serotonin levels post
intervention in the treatment group.
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There have been no prior published studies measuring serum serotonin as a marker
of neuroendocrine function in the absence of neuroendocrine disease states such as
carcinoid. There is evidence that serotonin levels in the central nervous system fluctuate in
response to moods, but no studies were located on mood and serum serotonin levels.
There also is no literature on the appropriate time to measure serum serotonin levels.
Perhaps changes in serum levels occur over a longer span of time than the 4-week interval
in this trial . It is conceivable that changes occur not in serum levels, but in central receptor
sites. Serum serotonin levels may remain relatively stable over time in the absence of
neuroendocrine disease. Perhaps more importantly, sustained levels of well-being may be
necessary to increase serum levels. The data indicate a downward trend in post
intervention levels. It is possible this finding correlates with an increase in receptor-laden
serotonin or conceivably an increase in intersynaptic serotonin. Additionally, there is a
wide normal range for serum levels (2 1 -3 2 1 ng/ml) making it more difficult to discern the
physiological or clinical significance of changes. Finally, there is a vast variation in the
levels intraindividually as well as across individuals. Perhaps serial levels are needed daily
or weekly to ascertain significant changes.
DHEA and Cortisol. Although the multivariate physiological model was not
statistically significant, the exploratory univariate model examining cortisol was significant
while controlling for baseline cortisol, DHEA, CD4+ lymphocyte percentage, and
rHCMSS score. Salivary cortisol levels declined in the treatment group and increased in
the wait-list control group. There was no detectable change in DHEA levels post
intervention.
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Measurement of salivary DHEA and cortisol is established in the literature. It is
accepted that stress and negative affective states increase cortisol and decrease DHEA
levels. No published reports were found concerning positive affective states and
cortisollDHEA levels. However, it was postulated that if negative affective states
negatively impact this ratio, then positive affective states might have a positive impact, but
these hypotheses were rejected.
In this study an ultrasensitive, standardized ELISA assay was used to measure
cortisol, but the DHEA assay was the older radioimmunoassay. Perhaps the DHEA assay
used was not sensitive enough to detect subtle changes. However, significant
neuroendocrine changes would not be expected if those effects are predicated on
signifi c ant changes in well-being. Perhaps perceived stress is a stronger correlate of
cortisol and DHEA Changes in well-being may be related to responses to stress but may
not be sufficient to affect cortisol and DHEA levels.
Immune Measures
Lymphocyte subsets. Four lymphocyte subset measures were included in the
statistical analysis, CD4+, CD8+, CD5 7+, and CD8+/CD57+ lymphocytes. There were no
significant changes detected in lymphocyte subset percentages following HT. A downward
trend was observed in CD4+ lymphocyte levels in both the treatment and wait-list control
groups. There were similar downward trends in CD8+ lymphocyte levels in both groups.
CD57+ and CD8+/CD57+ lymphocyte levels were the same pre-to post-intervention in the
treatment group, but the control group demonstrated upward trends in this subset .
Acknowledging there is no treatment effect and given the trends in the data,
perhaps HT does not increase CD4+ lymphocyte percentage, but conceivably attenuates
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the disease-related decline over time. This is purely speculative because the data did not
support a change in CD4+ lymphocyte levels post-intervention and participants were not
assessed longitudinally. Although there was no detectable change in the percentage of
CD8+/CD57+ cells, there was a trend toward higher NK cell cytotoxicity.
NK cytotoxicity Although there is no significant change in the number of NK cells
as HIV disease progresses, NK cells become functionally defective (Brenner, Dascal, &
Wainberg 1 989; Chehimi et aI , 1 992; Sirianni, Tagliaferri, & Aviti, 1 990). In the
univariate analysis, the change in pre- to post-intervention NK cell cytotoxicity
approached significance (12= . 06). This trend is consistent with the assertion that functional
immune measures may be more sensitive than enumerative measures to psychosocial
factors (Kiecolt-Glaser & Glaser, 1 992; Schulz & Schulz, 1 992).
Cytokines. Clerici and Shearer ( 1 993, 1 994) proposed that a type 1 cytokine
pattern enhances cellular immunity whereas a type 2 pattern diminishes cellular immunity
and enhances humoral immunity. These researchers acknowledged that their theory does
not take into account interactions among all cell types in a dynamic system. The complex
nature of the cytokine system makes it a challenge to measure changes in cellular
production of cytokines. With this small data set, there is no clear demarcation of type 1
and type 2 cytokine patterns. There is essentially a type 0 pattern, indicating more normal
immune function in these HIV -seropositive individuals than originally anticipated.
Cytokines were the most promising, yet complicated and tenuous measures of immune
system function in this analysis.
Pulse. Because energy therapies are theorized to elicit the relaxation response,
pulse was measured before and after each treatment as an indirect measure of the
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relaxation response. Participants were allowed at least 5 minutes to rest prior to pulse
assessment . Although not statistically significant, there was a downward trend in mean
pulse rates post-intervention. However, it must be noted the decreases could have been
associated with rest alone because participants were lying down during their 3 0-minute
HT session.
In summary, there were no significant changes in well-being or neuroendocrine and
immune function following HT as it was delivered in this study. The theoretical basis for
the research hypotheses were sound. Explanations for rejecting the proposed hypotheses
include the true absence of a treatment effect, ceiling effects, inadequate treatment "dose, "
small sample size, and inadequate sensitivity of the chosen PNI-based measures. Based on
the results of this study, implications, strengths and limitations, and directions for future
research are offered.
Implications
As evidenced by the findings of this study, assessing the effectiveness of HT and
applying the results when making clinical decisions remains a challenge. This was a
rigorous scientifi c investigation into the effects of HT. It was specifically proposed that
HT had the potential to improve well-being, thereby eliciting favorable changes in the
neuroendocrine environment and ultimately enhancing immune function. Despite positive
results in the literature, all of the study hypotheses were rejected .
Prior research involving energy therapies and PNI has produced some positive
results, however many of the prior studies lacked adequate scientific rigor. This study was
theoretically and methodologically sound and contributes significantly to the growing body
of research in the area of energy therapies as well as PNI . The findings of this and
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previous studies indicate there is a need for additional well-designed studies to further
assess the efficacy of HT, which is increasingly being used in clinical practice.
Despite the limited statistically significant findings, each of the participants voiced
only positive comments about the HT treatments they received. Further evidence of the
participants' positive perceptions of the experience of receiving HT was the development
of a bi-monthly HT program for participants who requested continued HT treatments,
which started in October, 1 999 at a community service agency. Independent of these
findings, one of the HT practitioners who participated in the study established this
program with two of the other practitioners now participating as well as one of the study
participants who now helps schedule participants.
Strengths and Limitations
The major strengths of this study included its holistic approach based on a PNI
theoretical framework and its experimental investigation of the increasingly popular
complementary therapy of HT There have been no reports of well-designed experimental
trials on the effects of HT arising from a PNI paradigm. The psychosocial and
physiological measures were grounded solidly in the PNI framework, both theoretically
and empirically. The wait-list design was both ethically and scientifically sound, allowing
treatment of all participants and comparing the influences of a short-term, cost-effective
therapy on the subjective well-being and immune function of individuals living with HIV
disease. As recommended by Herbert and Cohen ( 1 993) multiple indicators of immune
function were included to increase the reliability of the characterization of the participants'
physiological environment and, subsequently, the understanding of relationships among
affective, neuroendocrine, and immune parameters.
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The most significant limitation was the small sample size. A larger sample size
would have increased power and stabilized variance in the statistical analyses. Despite the
short duration of this study, attrition was a known threat . There were three enrolled
participants who did not complete the study. Although this is a small number, given a total
sample size of 3 0, it was a notable level of attrition ( 1 0%) Individuals living with HIV
disease have unstable immune systems and potentially are coping with complex issues
which may make them more likely to withdraw from the study due to illness. Participant
enrollment continued until a total of 30 participants had been enrolled. Recruitment efforts
continued for 5 months but additional participants were not enrolled.
A second limitation involved the control of the HT intervention. The majority of
the TT research presented in the literature review involved 5-minute TT interventions. The
timing of the sessions in HT research has been more variable. Although practitioners were
allowed 20-30 minutes for HT sessions in this study, this did not allow sufficient time for
individualized treatment based on recipient needs. The intervention treatment time was
less than the typical 45-60 minute sessions in actual practice. The 20-30 minute time
restriction allowed the five HT practitioners to treat the necessary number of participants
in a timely manner without excessive fatigue. Additionally, the same techniques were used
with all participants. These restrictions were necessary to enhance scientific rigor but are
not consistent with the usual practice of this therapy. While this restriction limited
generalizability, such scientific control was necessary. Direct practice applications will
require further research.
Finally, this clinical trial was not longitudinal . The hypotheses tested in this study
involved the potential effects of HT on the neuroendocrine and immune environment in
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individuals living with HIY disease over only 4 weeks. Even if the statistical hypotheses
had not been rejected indicating there was a signifi c ant treatment effect, limited
conclusions could be drawn regarding the clinical significance of such short-term changes
in the study parameters.
Recommendations for Future Research
Adequate theoretical and empirical evidence supported this investigation of the
effects of HT on well-being, serum serotonin levels, DHEA and cortisol, and immune
function in individuals living with HIY disease. Research to date on energy therapies has
yielded primarily positive results, although further study using more rigorous methods is
warranted.
Recommendations for future research include well-designed experimental studies
with adequate sample sizes. Consideration of effect size is imperative. Effect size can be
increased with a larger sample size, more sensitive outcome measures, as well as
considerations related to strengthening treatment effects including an increased "dose" of
the intervention (increased frequency and longer duration of HT sessions). Additionally,
when interpreting findings, data and conclusions must be congruent . Although it is
appropriate to examine trends and draw inferences that contribute to understanding the
data and developing future research, if there is no statistically significant treatment effect,
conclusions are limited. Finally, despite prior evidence correlating affective states and
immune function, it is still unclear whether there are significant implications for health
outcomes in PNI-based studies. Longitudinal, outcome-based research is needed to assess
the impact of mind-body therapies, including energy work, on the HIY disease trajectory.
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Longitudinal research investigating the effects of HT is required to assess the long-term
impact on disease progression.
Based on the findings of this study, specific recommendations can be made
regarding the choice of outcome measures in future research. The Faces Scale is a valid
and reliable measure of well-being. It is also easy to administer and score. The use of this
scale should be considered in future investigations involving complementary therapies and
well-being.
Despite the absence of a statistically significant physiological model in this clinical
trial, there is substantial research to support continued exploration into neuroendocrine
and immune dysfunction in HIV disease as well as interventions that potentially enhance
immune function and impede HIV disease progression. Salivary measures of DHEA and
cortisol are methodologically sound, cost effective, and noninvasive measures of neuroendocrine function and should be considered in future studies.
Serum serotonin samples are complicated to process and expensive to assay. Until clearer
evidence is available, this may not be a good indicator of changes in the neuroendocrine
environment .
CD4+ lymphocyte levels are established as valid and reliable indicators of HIV
disease status and progression and must be considered in studies involving individuals
living with HIV disease, at least as covariates if not outcome measures. According to the
literature, functional measures are as important as enumerative measures when assessing
HIV disease progression. Research to date supports the use of lymphocyte proliferation
and NK cytotoxicity as indicators of immune function in HIV disease (Clerici & Shearer,
1 993, 1 994; Lucey et aI. , 1 99 1 ; Clerici, Roilides, & Butler, 1 992; Brenner et aI. , 1 989;
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Clerici et aI . , 1 989; Nott, 1 995) Cytokine levels are costly and complicated t o interpret in
a clinically meaningful way in the context of HI V disease. Nevertheless, cytokine
production is a promising measure of immune system function There is substantial
research to support the indirect immunoendocrine dialogue between cortisol and cytokines
and the progression of HI V disease (Norbiato et aI . , 1 997; DeKruyff, Fang, & Umetsu,
1 997; Blotta, Dekruyff, & Umetsu, 1 997).
Finally, research is needed to foster understanding of how individuals living with
HIV disease appraise the significance of their experiences, including the effects on their
daily lives as well as their long-term goals and aspirations. Well-designed qualitative
research will provide information about the experience of living with HIV disease and
provide directions for formulating future research questions and designs. Additionally,
qualitative explorations into the experience of giving and receiving HT may provide
knowledge about specific outcome measures, which is imperative because the mechanisms
of action of energy therapies remain poorly understood.
Conclusion
This was a well-designed interventional study of the effects of HT on well-being
and neuroendocrine and immune function in 27 males living with HIV disease, yet all of
the research hypotheses were rejected. Possible explanations for the lack of a treatment
effect include that HT did not work, the lack of statistical power to detect a treatment
effect related in part to a small sample size, and a high level of participant well-being at
baseline, among others. Although there was no detectable enhancement of well-being and
neuroendocrine and immune function in the participants in this study, there was no
indication of harm and participants perceived positive benefi t s while receiving HT. The
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potential impact of positive affective states on well-being has remained largely unexplored.
This research contributes to the developing knowledge base of energy therapies. These
results do not support the use of HT in HIV care. Further research is need before the
decision can be made regarding the therapeutic use of HT in HIV care.
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APPEN D I X A:
D IAGRAM OF TH E S EVEN MAJ O R C HA K RA S

Crown
Forehead
Throat
Heart

Base

A. The

seven major chakras

Brennan, B.A. ( 1 987). Hands of l ight: a guide to h e a l i ng t h rough the human e n e rgy fi e l d .
York: Bantam Boo ks

New

A P P E N D I X A : PH YSIOLOGIC CON NECTIONS A N D T H E MAJOR CHAKRAS

CHAKRA

E N DOCRI N E G L A N D

AREA OF B O D Y GOVERNED

•

I - Base

Adrenals

Spinal column, kidneys

•

2-Sacral

Gonads

Reproductive system

•

3-Solar Plexus

Pancreas

Stomach, liver, GB, PNS

•

4-Heart

Thymus

Heart/circ.system, vagus
nerve

•

5-Throat

Thyroid

Throat, P u l m . and G I

•

6-Head

Pituitary

Lower brain, L eye, ears,
nose, nervous system

•

7-Crown

Pineal

Upper brain, R eye

Adapted from Brennan, B . A ( 1 987). Hands of light: A gu ide to healing through the human
energy field. New York: Bantam Books

APPENDIX B :
C H A K RA CONN ECTION TECHN I Q U E

Mentgen, J . & Bulbrook, M. ( 1 99 5 ) Healing touch level II notebook (pp. 98- 1 02).
Carrboro: North Carolina Center for Healing Touch
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A P P E N D I X A: Diagram o f the Seven M ajor Chakras ( Placement and Physiological
Connections)
A P P E N D I X B: Chakra Connection Tec h nique and HT Assessment Tool
A P P E N D I X C: Data Record Form
CDC Classification Form
Revised H I V Medical Center Staging Scale
Karnofs ky Performance I ndex
Cognitive Capacity Screening Exam ination
APPENDIX D : Psychosocial I nstruments
•

General Well-Being Schedule (GWB)

•

Faces Scale

•

B rief Profile of Mood States ( POMS)

•

H u m a n Field I mage Metaphor Scale (HFI MS)

•

I mpact of Events Scale ( I ES)

APPENDIX E

Consent Form

APPENDIX F

Cytokine Data

C H A K RA C O N N E C T I O N
#5

#6
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#8
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C H A K RA C O N N E CT I O N
#9

#1 1

1 00

C H AKRA C O N N ECTI O N
#13

#14

#15
#16
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C H AKRA C O N N ECT I O N
#17

#18

#19
# 20

1 02

Client:,
Date:

_
_
_
_
_
_
_
_
_
_
_
_

_____

,Session , :
_

ASSESSM ENTI FINDINGS:

_
_
_

ENERGY TREATMENT! FINDINGS:

APPENDIX C :

•

D ata Record Form

•

CDC C lassification Form

•

Revised " IV Center Medical Staging Scale

•

Karnofsky Perfo rmance Index

•

Cognitive Capacity Screening Examination

Date of enro llrnerv

G RO U P

__'--_

_

N � e __

Contact Telephone

_
_
_
_
_
_
_
_
_
__
__
__
__
__
__
__
_
_
___

Mailin g Address

I D CODE

______

_____

__

_
_
_
_
_
_
_
__
__
__
__
_
__

_
_--:-_____-______------------___-----------DATA RECORD HERE. Allach above identif�'ing i n formalion 10 I NFORMED CONSE:'OT DOCUMENT.-

__
_

-D ETACH FROM

------------. . . . . . ---------------------------------- _ . - - - - ----------- - _ . _ . _ . - - _ . _ . _---------- - -

Recru itment Source

G ROUP

_
_
_
_
__
__
__

ID CODE ______

_____

_

OAT A RECORD :
KARNOFSKY

(� 6 0 )

COGNITIYE EXAM

_
__
_

Attachmenl

( � 20)

Anachment

___

_

2

C DC C LASS ____

__

Anachment 3

Attachment <I

RAC E : I = B lack. 2 = H ispanic. 3 = White. 4=Other

= ___
AGE_
=_ YEARS of E DU C A TION_
_

PARTNER STATU S :

rHCMSS

__
__
__

I

__

_

I =Single, never married; 2 = Married or Life Parmer: 3 =Divorced or Separated; 4=W idowed

DATE OF FIRST·KNOWN H I Y · [N FECTED D IAGNO S I S

_

__
_

PRE·BASE C D4 : ( � 50 within J months FOR BLOODl
Date

Count

%

__

_

U S U A L WE I G H T ( i e .. normal weight prior to
illness-related weight lossl

__
___

ALCOHOL USE:

RlSK FACTORS:

I and 2

I.
2.
3.

B lood

5.

Combination

Homosexuallbisexual

6.

Comb ination 1 and 3

.,

Heterosexual

7.

Combination 1 and 4

3.

4.

Injection

8.
9.

Combination 2 and 4

4.

� 3 drinks/day

Combination 3 and 4

5.

Binging (i.e., excessive intake

1.

None or rare ly
s

3 drinks/week

s

2 drinks/day

that occurs in irregular pattern )

6.
CURRENT MEDICATION S : (No steroids. i m m u nomodulalors,
Stan date of c u rrent Rx

_
___
_____

__

#5 ... consistent pattern of intake

PSYC HOTROPIC DRUGS (Prescribed):
( Descriptive)

__
__
__
__
__
__
__
__
__
_
__

C ircle all that apply:
O.

None

PSYCHOACTIYE DRUG USE ( I l l icit):

AZT ( Retrovir)

5.
6.

HC (Epivir)

I.

Nevirapine

(Descriptive)

2.

ddC (HIYID)

7.

Protease Inh ibitor

3.

ddl (Yidex)

4.

d4T (ZeritiStavudine)

( A L SO code 1 ·6.8)

8.

Other

FREQUENCY OF USE:
1.

_
__
__
__
__
_
__
__

USE OF COMPLEMENTARYIAL TERNA TIYE TH E RA P I E S (Descriptive)
EXERCISE

_
__
_
__
__
__
__
__
__
__
_

None or rarely
3 times/week

2.

s

3.

Daily

____________

_
_

PATTERN:

(Descriptive)

______

I.
2.

Minimal

3.

Moderate aerobic

[Occupational e�ercise may

be coded

as 1/2 or 1/ 3 . depending on

level of activity

S poradic, effortful

I

4.

( I unit 3 X1wk) (e.g .. one aerobic ··unit" · 20-minute cycling. 4 5 -minule brisk walking. jogglOg < 3 miles'
Routine aerobic (� 3 unitslwk or conditioned intense) (e.g .. jogging � 3 miles. 5 times I week)

5.

Maximal aerobic or unconditioned intense ( e . g .. competitive runmng. cycling. weight training) (Not within 24 hours,

DATA RECORD ATIA C H M E NT
1 993 Revised

.2.

C D C Classification Svstem for HIV I n fection (CDC, 1 99 2 b )
.

C L I N ICAL CATE G O R IES
C D4+ T-Iympbocyte

(A)

(8)

(C)

Asym ptomatic. acute

Symptomatic.

A IDS-indicator

( p ri ma ry ) H IV o r P G V

n o t (A) or ( C ) conditions

conditions

( 1 ) � 500/microliter

Al

Bl

Cl

(2) 200-499/J.LL

A2

B2

C2

(3) <200/J.LL

A3

B3

C3

COUNT

Clinical Cat e20ries

Category A consists of one or more of the conditions listed below in an adult or adolescent ( � 1 3 ) with documented HIV infection.
Conditions listed in Categories B and C must not have occurred.
Persistent generalized lymphadenopathy
Asymptomatic HIV infection
Acute (primary) HIV infection with accompanying il lness or history of acute HIV infection

C ategory B consists o f symptomatic conditions in an HIV -infected adolescent or adult that are not included among conditions
listed in clinical Category C and that meet at least one of the fol lowing criteria: (a) the conditions are artributed to HIV infection or
are indicative ofa defect in cell-mediated immunity; or ( b ) the conditions are considered by phys icians to have a clinical course or
to require management that is complicated by H I V infection. Exam ples of clinical conditions in category B include, b ut are not
limited to:
Candidiasis. oropharyngeal (thrush)
Bac i llary angiomatosis
Idiopathic thrombocytopenic purpura
Hairy leukoplakia. oral
L isteriosis
Peripheral neuropathy
Candidiasis, vulvovaginal: persistent, frequent. or poorly responsive to therapy
Cervical dysplasia ( moderate or severe)/cervical carcinoma in situ
Constitutional symptoms. such as fever (3 8 . 5 C ) or diarrhea lasting > 1 month
Herpes zoster (shingles). involving at least two distinct ep isodes or more than one dermatome
Pelvic inflammatory disease, panicularly if complicated by tubo-ovarian abscess
For c lassification purposes. Category B conditions take precedence over those in Category A . For example. someone prev iously
treated for oral or persistent vaginal candidiasis (and who has not developed a Category C disease), but who is now asymptomatic
should be classified in c l inical Category B .

C ategory C includes the c l in ical conditions listed i n the A IDS surveillance case definition ( l isted below ). For c lassificJtion
purposes, once a Category C condition has occurred. the person will remain in Category C.
Candidiasis of bronchi. trachea. or lungs
Candidiasis. esophageal
Cervical cancer, invasive
Cryptococcosis, extrapulmonary
Cytomegalovirus retinitis (with loss of vision)
Encephalopathy, HIV -related
Kaposi's sarcoma
Lymphoma. Burkitt's (or equivalent term)
Lymphoma. immunoblastic (or equivalent term )
Lymphoma. primary, of brain
Pneumocystis carinii pnewnonia
Pneumonia. recurrent
Progressive multifocal leukoencephalopathy
Salmonella septicemia. recurrent
Isosporiasis, chronic intestinal (> 1 month's duration)
Wasting syndrome due to HIV
Coccidioidomycosis, disse m in ated or extrapulmonary
Histoplasmosis. disseminated or extrapulmonary
Cryptosporidiosis. chronic intestinal (> 1 month's duration)
Toxoplasmosis of brain
Cytomegalovirus disease (other than liver. spleen, or nodes)
Herpes simplex: chronic ulcer( s ) (> 1 month's duration); or bronchitis. pneumonitis, or esophagitis
Mycobacterium avium complex or M. /cansasii, disseminated or extrapulmonary
Mycobacterium tuberculosis. any site (pulmonary or extrapulmonary)
Mycobacterium, other species or unidentified species. disseminated or extrapulmonary

O AT A RECORD A IT ACHM ENT a.

( I . Interview participant

2. Check medical record)

Revised HIV Center �edical Staging System ( rHC MSS)
Scoring Instructions: Based on history and physical examination data. but independent ofCDC claSSification and immune

� derive a numerical score between 0 and 3 9 to categorize an individual's HIV-specific health status. First. categorize the

individual by one of the major stages: Asymptomatic. M inor S ymptoms. Major Symptoms. or A I D S . Second. categorize the
severiry of symptomatology w ithin the des i gn ated stage by assi gning a score from 0-9. 1 0- 1 9. 20-29. or 3 0-3 9 .
�ote that scores are assigned for any history or current evidence of a given symptom: once a staging score has been assigned.
it cannot decl ine on subsequent examinations. A N C H O RED rN DICATORS A RE APPROXIMA TIONS O N L Y: actual scores
may inc lude all integers and are based on c l in ical judgment.
Range

S tage: Description a n d I n d icators
Asymptomatic: Phys ical symptoms may be anributed to HIV infection. but are not. in themselves. of clin ical
concern.

0-9

o

2

No history of symptoms

5

:::

Minor fatigue ( less than 25% reduction

9

::: > usual U RI s

10

normal activity)

M i n o r S y m ptoms: L im ited. but c l in ically signi ficant symptoms wh ich are not included below (e.g . . persistent

1 0- 1 9

generalized lymphadenopathy. oral or vulvovaginal candida. skin and nail infections or rashes. constitutional
symptoms of lim i ted duration. episodic diarrhea. fatigue w ith 25-50% reduction in normal activiry. Cervical
dysplasia [erN 1 -2 1

1 0 ::: PGL
1 5 :::

1 9 :::

__

__
__

__
__
__
__
__
__

_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_

Oral hairy leukoplakia ( O H L )
Salmonella septicemia ( once )
Pneumococcal bacteremia
H. influenza bacteremia
Weight loss > 1 0% body wt

O t her :

30-39

_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_

3 symptom episodes : L ist

�

Major Symptoms: Serious physical symptoms. but not AIDS-defm ing conditions. inc luding the fo l lowing
(check i f app licable):

20-29

__

:0; 2 symptom episodes : L ist

__

Pelvic int1ammatory disease ( P I D )
:-.l ight sweats > 30 days
Cervical dysplasia ( C rN 3 )
Fever > 30 days
Peripheral neuropathy
Diarrh ea > 30 days
Fatigue > 30 days
HerlJes zoster
I diopathic thrombocytopenia pUrlJura I ITP)
__

__

__

__

__

_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_

20 :::

:0;

2 symptom episodes

2 5 :::

Recurrent major symptom episodes

2 9 :::

ChrOniC andlor multiple major symplOm episodes

AIDS: Any A I DS-indicator condition. inc luding the fol lowing (check if app licable):
Candidiasis, esophageal or pulmonary
C occidioidomycosis
(disseminalcd [ds1 or extrapulmonary [ep) )

Cryptococcosis (ep)
Cryptosporidiosis. chronic intestinal

Cytomegalovirus (not liver. spleen. or nodes)

Encephalopathy

Isosporiasls. chronic intestinal
MAC. M. kansasii or other (ds. ep)
M . tuberculosis. any site
Pneumocystis cartnii pneumonia ( PC P )
Recurrent pneumonia
Progressive mulufocal leukoencephalopathy
Recurrent Salmonella septicemia
Toxoplasmosis of brain
Wasting syndrome
Malignancy, SPECIFY: _ KS _lymphoma_invasive cer. lcaJ

__
__

__

Histoplasmosis (ds. ep)
HerlJes simplex
(chronic, esophagus, pulmon ary )

__

__

30

:::

� 2 AIDS-indicator illness episodes andlor conditions of limited severity

35

:::

Recurrent indicator conditions

3 9 ::: Chronic andior multiple opportUniStiC I n tectlons
C McCain. Lyon. Higginson. Senle. &: F , ,"cr d96

DA T A R ECORD A IT A C H M E NT J

KARNOFSKY PERFO R.J'v1 A ;\ C E rN DEX

DEFrN lTION

C RlTERlA

1 00

Able to carry o n normal activity
and to work. No special care
is needed.

Unable to work. Able to live at home.
care for most personal needs. but
a varying amount of assistance
is needed.

Normal: no complaints: no evidence of disease

90

A b le to carry on normal activity: m inor signs
or symptoms o f disease

80

N ormal activity w ith e ffort: some signs or
s: mptoms o f disease.

70

C ares for s e l f. but unable to carry on normal
activity or to do active work

60

Requ ires occasional assistance. but is able to
care for most personal needs
I'I/ot eligible

....;�'--______________
=

Unable to care for se lf. Requires
equivalent of instirutional or
hospital care. Disease may be
progressing rapidly.

50

Requ ires cons iderable assistance and
frequent medical care

40

Disabled: requires special care and assistance

30

Severe ly disabled: hospitalization i s i ndicated
aithough death not imminnent

20

Very sick: hospitalization necessary; active
supportive treatment necessary

10

\loribund: fatal processes progressing rapidly

o

Dead

Kamofsky. D . A .. Abelmann . W.H Craver. L . F . & Burchenal. 1 . H . ( 1 948). The use of the nitrogen mustards in the
palliative treatment of carcinoma. Cancer. I, 634-656.
.•

.

DATA RECORD ATTAC H M E N T "

COGN ITIVE C A PAC ITY SCRE EN rN G EXA M [}.; A TlON

Instructions' Check items answered correctly. Write incorrect or unusual answers in space provided. I f necessary. urge
pati en t once to complete task. Introduction to patient " I would l ike to ask you a few questions. Some you w i l l find very
easy and others may be very h ard. Just do your best."
C S E C L rNICAL JUDGMENT TO A S S E S S : ( RE ru RN TO T H E S E ITEMS I F SCORE
I ) What day of the week is this?
2) What month"
3 ) What day o f month?
4) What year?
5 ) What place i s th is?
6) Rep eat the numbers 8 7 2.
7) Say them backwards.
8 ) Repeat these numbers 6 3 7

<

20 OR QUESTION A B L E . )

BEGrN H E RE WITH SPEC IFIC ITEMS, U P TO TOTAL OF 20 POrNTS
9)

L isten to these numbers 6 9 4. Count I through 10 out loud. then repeat 6 9 4 . ( Help if needed.)

1 0)

Listen to these numbers 8 I 4 3 . Count I through 1 0 out loud. then repeat 8 I � 3 .

I I)

Beginn ing w ith Sunday, say the days of the week backwards.

12)

9

1 3)

Add 6 (to the previous answer or "to 1 2").

I �)

Tak� away 5 (" from 1 8" ) .

..

3 is

REPEA T T H E S E WORDS A FTER M E A N D RE M E M B E R T H E M . I w i l l ask for them later: HAT. CAR. TREE.
TWENTY · S I X .
1 5)

The opposite of fast is slow. The opposite of up is

1 6)

The opposite of large is

1 7)

The opposite of hard is

1 8)

An orange and a banana are both fruits. Red and blue are both

19)

A penn y and a dime are both

__ .

__ .

__ "

__

.

20) What were those words I asked you to remember? (HA T)
22) (TREE)
24)

Take away 7 from 1 00, then take away 7 from
what is left and keep going: 1 00 - 7

25)
27)
29)

M inus 7

(26)
(28)
(30)

OR

is

M inus 7

(2 1 ) (CAR)
(23 ) ( TWENTY·S I X )
Spell WORLD backwards
( inten·iewer spell W-O-R-L-D)
Score

I po int for each lener:

R
0
(27)
W
(28)
EACH ITEM COUNTS A S ONE POrNT; TOTAL CORRECT MUST B E G REA TE R THAN 1 9 . ( Maximum score
M inus 7

M inus 7

M inus 7

M inus 7

Jacobs e t at. ( 1 977). Annals ofInternal Medicine. 86, 40·�6.

(24)
(25)

D
L

(26)

=

30)

APPENDIX D :
G E NE RA L WELL-BEING SCH E D U L E

McDowell, I . & Newell, C. ( 1 996) . Measuring health: A guide to rating scales and
questionnaires. 2nd ed. New York: Oxford University Press

These are q uestions about how YOll ree l and how t h i ngs have been g o i n g w i th y o u .

For

each questions. mark (X) beside the answer which best app li es to you.

1.

H o w have you been fee l i n g in general ? ( d u r i n g the past m o n t h )

-----

2.

In exc e l lent spirits
I n very good spirits

3.

I n good spirits mostly

4.

I have been up and down in spirits alot

5.

In low spirits mostly

6.

I n very low spirits

Have you been bothered b y nervou sness o r y o u r " ne rv e s " ,? ( d ur i n g the past month)
Extre m e l y so- -to the p o i n t where I c o u l d n o t work o r take c are

--

l.

--

2.
..,

Very muc h so

J.

Quite a bit

4.

Some-enough to bother me

----3.

1.
2.

of things

5.

A

6.

Not at al l

l ittle

Have you been i n firm control of y o u r beh:n· i o r. thoug hts. � l11 o t i ons. O R fee l i n g s .)
( duri n g the past month)

-------

4.

1.

Yes. definitely so

2.

Yes. for the most pan

3.

Genera l l y so

4.

Not too well

5.

No, I am somewhat d i sturbed

6.

No, I am very disturbed

Have you felt so sa d. d i scouraged, hope l ess. or had so many problems that you
wondered if anything was worthwhi le? ( d u r i ng the past month)

-------

1.

Extremely so--to the point that I have j ust about g i ven up

2.

Very much so

3.

Quite a bit

4.

Some--enough to bother me

5.

A

6.

Not at all

l i tt l e bit

5.

H ave you been under o r fe lt you were under any stra i n . stress. o r prcssurl!·.' ( d uri n g
t h e past month)

1.

Yes--a l most more that I could bear or stand

--

2.

Yes--quite a b i t o f pressure

--

3.

Yes--some. more than usual

--

4.

Yes--some, b u t about usual

--

5.

Yes"'-a l ittle

--

6.

Not at al l

--

6.

H o w happy , sat i s fi ed . or p l eased have you been w i t h y o u r pl!rsonal l i fe') ( d uri ng the
past month)

--

1.

Extremely happy--could not have been more satisfied o r
pleased

--

2.

Very happy

--

3.

Fairly happy

4.
5.
6.

S atisfied--pleased

--

--

--

7.

S omewhat d i ssatisfied
Very d i ssatisfied

Have you have any reason to wonder i f y o u v" l! re losing y n ur m i n d . or l o s i n g
control over the \vay y o u ac t . tal k. think. fee l . or o f yo ur memory" ( d u r i n g t h e past
month)

--

1.

Not at a l l

--

2.

O n l y a l ittle

..

J.

Some--but not enough to be concerned or worried about

4.

Some and I have been a l i ttle concerned

--

5.

Some and I am q u i te conce rned

--

6.

Yes, very much so and I am very concerned

--

--

8.

9.

Have y o u been anxious. worried. o r u pset? ( d uring the past month )

--

\.

Extremel y so--to the po i nt o f be i ng s i c k or a l most s i c k

--

2.

Very much so

--

3.

Quite a bit

--

4.

Some--enough t o bothe r m e

--

5. -

A little bit

--

6.

Not at all

H ave y o u been waking up fresh, a n d rested? ( d u r i n g the past month)

--

1.

Every day

--

2.

Most every day

--

3.

Fairly often

--

4.

L ess than hal f the time ·

--

5.

Rare l y

--

6.

None of t h e time

1 0.

H ave you been bothe red by a n y i l l n\.!ss. bod i l y d i sn rd e r . p a i n s .

l) r

k:'lrs ahout y o ur

health? ( d uring the past month )

II.

--

1.

All the time

--

2.

Most o f the time

--

3.

A good bit o f the time

--

4.

Some of the time

--

5.

A little o f the time

--

6.

None of the time

Has your daily l i fe been fu l l o f things that wert! i n terest i n g to y o u ': ( d u r i n g the p a s t
month)

--

I.

--

2.

Most of the time

--

3.

A good bit o f the time

--

4.

Some of the time

--

5.

A little o f the time

6.

None o f t h e time

--

1 2.

13.

A l l the time

H ave you fe l t down-hearted and b l ue? ( du r i n g the past month )

--

I.

A l l the time

--

2.

Most o f the time

--

3.

A good b i t o f the time

--

4.

Some o f the time

--

5.

A l i ttle o f the time

--

6.

N o n e of t h e time

H ave y o u been feel i ng emot i o nal l y stab le and sure o f yourse l f') ( d uring the past
month)

1 4.

--

I.

A l l the time

--

2.

Most of the time

--

3.

A good bit of the time

--

4.

S o m e of t h e time

--

5.

A l ittle o f the time

--

6.

N o ne of the time

Have you felt tired. worn out. used-up. or t! x hallstcd') ( d u r i n g t h e past month)

--

1.

A l l the time

--

2.

Most of the time

...

J.

A good bit of the time

--

4.

Some of the time

--

5.

A little o f the time

--

6.

None of the time

--

For each o f the four scales b e l o \\". note that the words :.It ea c h end o f t h e 0 to 1 0 scale
C i rc l e :.Iny n u m ber along the bar which sl!e m s c l o ses t to h o w

describe opposite feelings.

y o u generally felt during the past m o n t h .
1 5.

.

How concerned or worr i e d about y o u r H E A L T H ha v e y o u bee n ?

( duri n g the past

month )

0

1

I

I

2
,

5

4

3
I

7

6
I

,

I

9

8

10
I

I

I

I

Not

Very

concerned

concerned

at all
1 6.

How RELAXE D or T E N S E has you been ? ( du r i n g the past month)
o

I
,

2

3

4
I

5
I

6
,

7
I

9

8
I

I

10
I

I

V ery

Very
relaxed

1 7.

tense

How much ENERG Y . P E P . V I TA L I T Y ha\ e y o u fe l t'} ( d uri n g the past m o n t h )
0

1

,

,

2
,

...

4

J

I

5
,

I

6

7
I

I

8

9
I

I

I

Very

No energy

ENERG ETI C .

AT ALL,
listless

1 8.

10

dynamic

How D EP RE S S E D or C H E E Rf U L h av e you been ) ( d u ri n g the past m o n t h )
o
,

1
,

Vory . '

2

3

4
,

.

.

depressed

5
I

7

6
I

,

8
I

9
I

10
I

I

Very
cheerful

GEN ERAL WELL-BEING I N STRUM ENTS: FAC ES S CALE

©QOQQGQ
A

8

C

Andrews, F. & Wi they, S . ( 1 976).

0

E

F

C

Social i n dicators of we l l -h e i ng. New York: P l e n u m

APPENDIX D
H uman Field I mage Metaphor Scale

Please read each of the following metaphors and indicate how you feel at the moment. C heck the
box that best describes how you identify with each stateme nt. If you do not identify with the

state ment. check the box under, "do not identify". If you identify strongly with the s tatement. check
the box under "strongly identify". There are no right or wrong answers.

I Feel ...

Do �ot

S l i ghtly

I dentify

I de ntify

Strongly

Moderately

Totally

I dentify

I denti fy

I denti fy

1.

free as a bird.

2.

one with the u niverse.

3.

like an eternal song.

----

-----, _____

4.

like a melody.

____

----_ . _----, _____ _
_
_
-

5.

like a tree in winter.

6.

like a fenced in yard.

I .

----,----,- ----,-- ----,-- -----

,

,1____,_ ---,1

like a symp hony.

8.

like a ray of light.

9.

like a bird in a cage.

1 0 . like a n ocean breeze.

----, --------' ----_.

.1

_____ _
_
_

__f_____

_
_
_
_ _
_
_
_
_ _
_
_
_

�/

, _
_
_
_

f

_____ _
_
_
_
_ _
_
_
_
_ _
_
_
_

_
_
_

1 1 . like a kite with no wind.
1 2 . one with the world.

____f

_____

______

______

f

_
_
_
_

1 3. like a ray of hope.
1 4. like a worn out shoe.
1 5. like I can touch the stars.

____f

_
_
_
_
_ _
_
_
_
_
_ _
_
_
_
_
_ _
_
_
_
_

.1

,
_____ ------

____

-------' -----

16. like a fragrance on the wind.

1 i. like I ' m s tanding on the
highest mountaiJI.

1 8 . like ripples on

a

pond.

19. like a free spirit

____

,f

_
_
_
_ _
_
_
_
_ _
_
_
_
_
_____ _

,f

---�

_____ _
_
_
_

,I

�/

_
_
_
_
_ _
-

20. like a new pair of s kates
2 1 . like a tree in springtime.

f

I

----'f

_
_
_
______ _

____ _____

_
_
_
_

22. like a garden in spring.
23. like an artist with a brush

____ _____

24. like I can see forever.

____

25. like my hands are tied.

_
_
_

f

f____,_

,f

f__,___ __,f___

� ____f__

_
_
_
_
_ _
_
_
_
_

_
_
_
_

f

__
_
_
_

APPEND IX D
B ri e f Poms

Below � a list of words that describe feelings people have . Please circle the number that best
describes how you have been fee ling

during the oast week. including today.

Not At

A

All

L i ttle

Moderately

Quite

Extreme ly

A Bit

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

:3

4

2

:3

4

I.

Unhappy

-

2.

E nergetic

-

3.

Sad

-

4.

On Edge

-

5.

Carefree

-

6.

B lue

-

7.

Uneasy

-

8.

C heerful

-

9.

Discouraged

-

0
0

1

2

:3

-!

0

1

:2

:3

-!

0

1

2

:)

-!

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

1 0 . Miserable

-

I I . Relaxed

-

1 2 . M u ddled

-

0

1

:2

3

4

1 3. Gloomy

-

0

1

2

3

4

1 4. Alert

-

°

1

:2

:3

4

1 5. Weary

-

0

1

2

3

4

1 6. Bewildered

_0

1

2

:3

4

1 7 . Ready to fight

_0

1

2

3

4

my illn ess

IMP ACT OF EVENT SCALE
Below is a list of comments made by people with HI V - infection or AIDS. Please check the appropriate
colUmn to indicate how frequently these comments were true

for you durini the past 7 dan.

If they did

not occur during that time, please mark the " not at all" column.

('1

-

"

�

...
�
...

i
I . [ thought about it when I didn ' t mean to.
2.

[ avoided letting myself get upset when I thought about i t o r w as reminded o f it.

3 . I tried to remove it from memory.
4.

[ had trouble falling asleep or stayin g asleep, because of pictures or thoughts
about it that carne into my m ind.

S . I had waves o f strong feelings about it.
6 . I had dreams about it.

7. [ stayed away from reminders about it.
8 . I felt as i f it hadn't happened o r i t wasn't real.

9 . I tried not to talk about it.

1 0 . Pictures about i t popped into m y mind.
I I . Other things kept making me think about it.
1 2 . I was aware that I still

had a lot of feelings about it. but I didn ' t deal with them.

1 3 . I tried not to th ink about it.
1 4 . Any reminder brou&ht

back feelings about it.

I S . My feelings about it wen kind of numb.

�
�

�
�

E
....
�
:;
..
!I
t:
..
r::

0

"'"
""

Page

1

APPENDIX E :
CONSENT FORMlResearch Information Sheet
Dissertation Title: Healing Touch in H IV Disease

of 2

Principle Investigators: Nancy L. McCain, RN, DSN
Jo L. Wheeler Robins, RN, MS, ANP
Faculty Advisor: Nancy L. McCain, RN, DSN
Medical College of Virginia HospitalsNirginia Commonwealth University
You are being invited to participate in a research study on the influences of healing touch
in persons with HIV infection. If you decide to participate, you will be one of 30 people who will
be involved in this study. The study is designed to examine the effects of healing touch on wellbeing, selected immune-related hormones, and several blood tests of immune system function.
Healing touch is a therapy based on the idea that the human body is made up of energy
and that imbalances or blockages in the flow of that energy can impair health and well-being.
Energy based therapies have been shown to increase wel l-being and they may also enhance
immune system functioning. The healing touch session will last 20-30 minutes and will involve a
nurse experienced in healing touch lightly placing her hands on specific areas of the body that
correspond with the theorized major energy centers of the body. Your participation also wil l help
us to understand the influence of well-being on the immune system in HIV disease, and we may
be able to provide better health care in the future. The only known risks or discomfort involved in
this research are the brief pain of a needle-stick when having blood drawn from an arm vein, and
the very sl ight chance of local infection at the site of the needle stick. Sterile procedures will be
used to minimize the risk of such infection.
If you decide to participate in this study, you will be involved for at least

4 weeks. In a

random manner similar to the toss of a coin, you will be assigned ( I ) to the healing touch group
or (2) to a wait list group to begin the study

4 weeks later. The healing touch treatment wil l

involve 3 0-minute healing touch sessions once a week for 4 weeks.
Research data will be collected at the beginning and end of the treatment group. If you
are assigned to wait for the intervention, you will also have data collected at the beginning and

Page 2 of 2

end of the wait list period. Data collection will require about 30 minutes of your time and wil l
involve having lab work drawn and completing a set o f four brief questionnaires. Additionally,
you will be asked to collect saliva samples the morning of data collection. At the 4-week data
collection time, you will be paid $50. You will not be paid or allowed to continue in the study if
you miss two of the healing touch sessions or a data collection time.
In the event of physical and/or mental injury resulting from your participation in this
research project, Virginia Commonwealth University will not provide compensation. If injury
occurs, medical treatment wil l be available at the Medical College of Virginia Hospitals . Fees for
such treatment will be bil led to you or to appropriate third party insurance.
Your participation is entirely voluntary, and you may decide not to participate or to
withdraw from the study without fear of disruption of the usual care, attention, or commitment of
any of your health care or social services providers. Your participation and the information
obtained wi l l be kept strictly confidential, and it will not be possible to identify any participant
from the reports or publications that may result from this research. You may ask questions now or
or Nancy McCain

at any time you wish in the future by contacting Jo Wheeler at
at

If you have any questions concerning your rights as a research subject, you

may contact the Committee on the Conduct of Human Research at

for

information or assistance.
Your initials here indicate that you understand the nature and requirements for your
participation in this research study, that you voluntarily agree to participate in the study as
outlined here and verbally explained to you, and that you have received a copy of this form.

YOUR INITIALS ONLY
Researcher's S ignature
Date:

_
_
_
_
_
_
_

APPENDIX F:
Cytokine Data
Participant 1 . 0.

I L-2

T N F-a

I L -4

I L-6

T reatment
G roup

02

Pre
Post

04

Pre
Post

06

Pre
Post

08

Pre
Post

12

Pre
Post

13

Pre
Post

16

18

8 84
1 85 3

353 1
4322

353
8 79

90 1
269 1

2 1 .4
50.7

2 7076
4235

78
7

1 99 1
223

30
2.9

275
67

5
362

<0 .5
27 1 5

269
3 1 .6

1 1 290
1 4746
46765
45573

8
48 1 1 6

1 007

54 1 7
348 1

3.3
1 .2

3 7939
3 78 1 8

Pre

1 3 07
1 3 53

3 348
3030

2.6
7.4

3 7780
2 8974

463
326

5 1 46

6.6

2 5 5 74

22
13

1413
9452

1 .8
1 .7

655
22652

1 5 23
725

5.9

Post

59
38

1 5553
9640

Pre

283

Post

1 293

2908
4760

5.1
8.2

3 8420
3 5 764

Pre

1 43 5
43 1

1 84 1
25 1 6

15.7

35427
5 10

Pre

Pre

Pre
Post

27

2 1 97
1 904

1 6829
252 1 3

934

Post

25

902
49 1

1 .3
8 .4

Post

Post

24

979
349 1

Pre

Post

22

24
1 14 1

Pre

417
302

Control Group

01

03

Post

05

07

09

Pre
Pos t

39
79

2676
1 260

<0 .25
5.1

3 1 22 1
3 1 34

Pre

1 05 1

2 1 49

3.3

35 1 30

Post

1 1. 1 5

Pre

325
1 03 3

1 557
2404

62. 1
1 95

1 4920
3 1 23

1 48
158

893
1 307

15

36825
39 1 47

18
459

3 060

893
449

2475
2396

9.8
1 6.4

8 5 5 65
5 9999

1714
13

2324
862

4.8
65 . 7

52738
47 1

Post

8 10

3983

3.3

48045

Pre

1 67
444

2825
3 3 69

24
1 7. 5

34548
1 95 8 8

44

1 8 32

Post

11

Pre
Post

14

Pre
Post

15

Pre
Post

17

Pre
Post

19

21

Pre

Post

28

5 8 202

Pre
Post

1 9943

